1
|
Villa F, Crippa A, Pelizzoni D, Ardizzoia A, Scartabellati G, Corbetta C, Cipriani E, Lavitrano M, Ardizzoia A. Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data. Int J Mol Sci 2023; 24:14427. [PMID: 37833875 PMCID: PMC10572355 DOI: 10.3390/ijms241914427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2023] [Revised: 08/31/2023] [Accepted: 09/08/2023] [Indexed: 10/15/2023] Open
Abstract
Cyclin-dependent kinase 4/6 inhibitors (CDK4/6iss) are widely used in first-line metastatic breast cancer. For patients with progression under CDK4/6is, there is currently no standard treatment recommended at the category 1 level in international guidelines. The purpose of this article is to review the cellular mechanisms underlying the resistance to CDK4/6is, as well as treatment strategies and the clinical data about the efficacy of subsequent treatments after CDK4/6is-based therapy. In the first part, this review mainly discusses cell-cycle-specific and cell-cycle-non-specific resistance to CDK4/6is, with a focus on early and late progression. In the second part, this review analyzes potential therapeutic approaches and the available clinical data on them: switching to other CDK4/6is, to another single hormonal therapy, to other target therapies (PI3K, mTOR and AKT) and to chemotherapy.
Collapse
Affiliation(s)
- Federica Villa
- Medical Oncology, Oncology Department ASST Lecco, 23900 Lecco, Italy; (A.C.); (D.P.); (C.C.); (E.C.); (A.A.)
| | - Alessandra Crippa
- Medical Oncology, Oncology Department ASST Lecco, 23900 Lecco, Italy; (A.C.); (D.P.); (C.C.); (E.C.); (A.A.)
| | - Davide Pelizzoni
- Medical Oncology, Oncology Department ASST Lecco, 23900 Lecco, Italy; (A.C.); (D.P.); (C.C.); (E.C.); (A.A.)
| | - Alessandra Ardizzoia
- School of Medicine and Surgery, University of Milano-Bicocca, 20126 Milano, Italy; (A.A.); (M.L.)
| | - Giulia Scartabellati
- Medical Oncology, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy;
- Department of Medical and Surgical Specialties, Medical Oncology, University of Brescia, 25121 Brescia, Italy
| | - Cristina Corbetta
- Medical Oncology, Oncology Department ASST Lecco, 23900 Lecco, Italy; (A.C.); (D.P.); (C.C.); (E.C.); (A.A.)
| | - Eleonora Cipriani
- Medical Oncology, Oncology Department ASST Lecco, 23900 Lecco, Italy; (A.C.); (D.P.); (C.C.); (E.C.); (A.A.)
| | - Marialuisa Lavitrano
- School of Medicine and Surgery, University of Milano-Bicocca, 20126 Milano, Italy; (A.A.); (M.L.)
| | - Antonio Ardizzoia
- Medical Oncology, Oncology Department ASST Lecco, 23900 Lecco, Italy; (A.C.); (D.P.); (C.C.); (E.C.); (A.A.)
| |
Collapse
|
2
|
Micoli C, Crippa A, Discacciati A, Vigneswaran H, Palsdottir T, Clements M, Aly M, Adolfsson J, Fredrik W, Wiklund P, James T, Lindberg J, Grönberg H, Egevad L, Nordström T, Eklund M. The Stockholm3 prostate cancer screening trial (STHLM3): An interim analysis of mortality results after 6.5 years of follow-up. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00930-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
3
|
Villa FM, Crippa A, Rosi E, Nobile M, Brambilla P, Delvecchio G. ADHD and eating disorders in childhood and adolescence: An updated minireview. J Affect Disord 2023; 321:265-271. [PMID: 36356347 DOI: 10.1016/j.jad.2022.10.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Revised: 10/12/2022] [Accepted: 10/17/2022] [Indexed: 11/09/2022]
Abstract
INTRODUCTION Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders with overactivity, inattention, and impulsivity as core characteristics. Recent studies suggest that 20 % of children with ADHD also develop eating disorders (EDs), including anorexia nervosa, bulimia nervosa and binge eating disorder. However, little is still known about the association between ADHD and EDs through childhood and adolescence. Therefore, in the present work, we aimed at summarizing the studies investigating ADHD and EDs in childhood and adolescence over the last 10 years. METHODS A bibliographic search on PubMed was performed and only studies that considered participants with a clinical diagnosis of ADHD, patients with an additional diagnosis of EDs and patients under 18 years old were included. A total of 7 studies were retrieved and included in the review. RESULTS The majority of the reviewed studies (N = 5) found an association between ADHD and EDs, while the remaining, which focused on EDs symptomatology, reported either lower ED symptoms in ADHD sample or no association between ADHD and EDs. LIMITATIONS the majority of studies were cross-sectional and therefore did not allow to explore the longitudinal casual relation between ADHD and EDs in the developmental age range considered. CONCLUSIONS This review suggests that children and adolescents with ADHD should be monitored for EDs. However, more work is still needed to better understand the clinical implications of the comorbidity between ADHD and EDs and its prospective impact on the life of children and adolescents with ADHD.
Collapse
Affiliation(s)
- F M Villa
- Child Psychopathology Unit, Scientific Institute, IRCCS E. Medea, 23842 Bosisio Parini, Italy
| | - A Crippa
- Child Psychopathology Unit, Scientific Institute, IRCCS E. Medea, 23842 Bosisio Parini, Italy
| | - E Rosi
- Child Psychopathology Unit, Scientific Institute, IRCCS E. Medea, 23842 Bosisio Parini, Italy
| | - M Nobile
- Child Psychopathology Unit, Scientific Institute, IRCCS E. Medea, 23842 Bosisio Parini, Italy
| | - P Brambilla
- Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
| | - G Delvecchio
- Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| |
Collapse
|
4
|
Villa F, Corbetta C, Crippa A, Pelizzoni D, Vittimberga I, Sansi C, Arnoffi J, Guida F, Cuomo O, Tafuni M, Sassone M, Viganò C, Anghilieri M, Ardizzoia A. Breast cancer management with CDK4/6 inhibitors as first line treatment: a single institution retrospective review. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)01535-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
5
|
Albanese C, Magli MC, Perruzza D, Terzuoli G, Azzena S, Crippa A, Tabanelli C, Gianaroli L. O-074 Whole genome amplification (WGA) of blastocoelic fluid (BF) as an additional criterion for the selection of the most viable embryo. Hum Reprod 2022. [DOI: 10.1093/humrep/deac104.088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
Is the presence or absence of DNA in the blastocoelic fluid detected by whole genomic amplification (WGA) a valid method to prioritize embryos for transfer?
Summary answer
Blastocysts with DNA in the BF have lower ongoing pregnancy rates compared with blastocysts without DNA, both in PGT-A and in conventional IVF cycles
What is known already
The detection of DNA in BFs from expanded blastocysts has been reported in different studies. After amplification, this DNA can be analyzed to provide information on the blastocyst chromosome condition, but the degree to which it is representative of the corresponding embryo ploidy is still controversial. The reason of this divergence could reside in several factors, including the different status of the studied embryos. A recent study comparing euploid and aneuploid blastocysts reported a significantly higher incidence of failed BF-DNA amplification in euploid blastocysts compared with aneuploid blastocysts suggesting an effect of the embryo ploidy condition on BF content
Study design, size, duration
This prospective study included 142 cycles with PGT-A (Group-1; 24-chromosome analysis was performed on trophectoderm (TE) biopsies) and 121 conventional IVF consecutive cycles (Group-2) treated in the last three years. In both groups, the BF was collected from expanded blastocysts before vitrification, and submitted to WGA. Single blastocyst transfers were performed by selecting blastocysts based on BF-WGA results giving priority to those with failed amplification. In Group-1, only TE-euploid blastocysts were transferred
Participants/materials, setting, methods
Patients in Group-1 had a maternal age higher than in Group-2 (36.8±3 vs 34.1±3.5 years). The same protocol of vitrification was used for all patients, and only expanded blastocysts of high grade were included in the study. Amplification after WGA was evaluated by loading an aliquot of the amplified product onto a 1.5% agarose gel. An ongoing pregnancy was defined as a pregnancy regularly ongoing beyond the 16th week of gestation
Main results and the role of chance
In Group-1, a total of 622 blastocysts underwent trophectoderm (TE) biopsy and 261 were euploid. The BF was retrieved from 237 euploid blastocysts and submitted to WGA. Amplification failure resulted in 98 BFs, whereas 139 BF gave a positive amplification. In all, 57 clinical pregnancies resulted, 53 of which were regularly ongoing. 61 transfers were performed with euploid blastocysts with failed BF-WGA, and 81 with positive BF-WGA. When looking at the transfer outcome, the ongoing pregnancy rate was significantly higher for euploid blastocysts with failed BF-WGA (31/61, 50.8%) when compared to those with positive BF-WGA results (22/81, 27.2%, p<0.01). In Group-2, there were 62 clinical pregnancies, 52 of which were ongoing. In relation to the BF-WGA results, the ongoing pregnancy rate showed the same trend of Group-1, and was 20% (52/121) for blastocysts with failed BF-WGA and 59.1% (42/71, p<0.001) for blastocysts with positive BF-WGA
Limitations, reasons for caution
This is a prospective cohort study. The results should be confirmed by a prospectively randomized study
Wider implications of the findings
The presence of DNA in the BF could be indicative of an abnormal embryos that is trying to reach a viable condition. Therefore, failure to detect DNA after BF amplification could represent an additional criterion to select viable embryos for transfer both in PGT-A and in conventional IVF cycles
Trial registration number
Not applicable
Collapse
Affiliation(s)
- C Albanese
- S.I.S.Me.R., Reproductive Medicine Unit, Bologna , Italy
| | - M C Magli
- S.I.S.Me.R., Reproductive Medicine Unit, Bologna , Italy
| | - D Perruzza
- S.I.S.Me.R., Reproductive Medicine Unit, Bologna , Italy
| | - G Terzuoli
- S.I.S.Me.R., Reproductive Medicine Unit, Bologna , Italy
| | - S Azzena
- S.I.S.Me.R., Reproductive Medicine Unit, Bologna , Italy
| | - A Crippa
- S.I.S.Me.R., Reproductive Medicine Unit, Bologna , Italy
| | - C Tabanelli
- S.I.S.Me.R., Reproductive Medicine Unit, Bologna , Italy
| | - L Gianaroli
- S.I.S.Me.R., Reproductive Medicine Unit, Bologna , Italy
| |
Collapse
|
6
|
Crippa A, Grazioli S, Rosi E, Mauri M, Villa F, Maggioni E, Diwadkar V, Brambilla P, Pozzi M, Molteni M, Nobile M. NIRS Hemodynamic Response to Methylphenidate in Children with Attention Aeficit Hyperactivity Disorder: First Administration, Titration Phase and Associations with Clinical Severity. Eur Psychiatry 2022. [PMCID: PMC9565663 DOI: 10.1192/j.eurpsy.2022.181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Introduction Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by lack of self-regulation and deficits in organizing behaviors in response to emotional stimuli. Methylphenidate (MPH) is one of the most effective psychostimulant drugs for ADHD, however, a possible predictive utility of brain hemodynamic data related to MPH administration and its relation to clinical symptomatology is still not clear. To address these questions, we used Near Infrared Spectroscopy (NIRS) technology, a non-invasive optical technique that allows to investigate the effect of psychopharmacological treatment on cortical hemodynamics. Methods Twenty children with ADHD underwent a three-waves study and 25 healthy controls were recruited at W1. At W2 children with ADHD received first MPH administration and at W3 they reached the titration phase. At each phase children performed - during NIRS recording - an emotional continuous performance task with visual stimuli of different emotional content. Clinical data were also collected at W1 and W3. We investigated the relationship among the difference between NIRS activation at W2 and W1 (Delta1) and W3 and W2 (Delta2), for each subject, task condition and brain region. Lastly, we investigated correlations between the Delta1 and clinical symptomatology indexes at W1 and between Delta2 and clinical data at W3. Conclusions Our study results suggest that hemodynamic changes in right prefrontal region probably induced by first MPH administration could predict hemodynamic changes related to MPH titration phase. These biological indexes could be associated to clinical evidences related not only to core ADHD symptoms but also to affective correlates. Disclosure No significant relationships.
Collapse
|
7
|
Mosconi P, Roberto A, Cerana N, Colombo N, Didier F, D’Incalci M, Lorusso D, Peccatori FA, Artioli G, Cavanna L, Ceccherini R, Cirigliano G, Comerci G, Cormio G, Crippa A, Farolfi A, Febbraro A, Giardina D, Greggi S, Lalle M, Lapresa M, Marzola M, Merisio C, Mosconi AM, Peiretti M, Ricci G, Ronzino G, Scambia G, Scollo P, Sina F, Stella GC, Tomao F, Vici P, Zola P. Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study. J Ovarian Res 2022; 15:45. [PMID: 35422000 PMCID: PMC9010065 DOI: 10.1186/s13048-022-00970-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2021] [Accepted: 03/18/2022] [Indexed: 11/30/2022] Open
Abstract
Background Despite several initiatives by research groups, regulatory authorities, and scientific associations to engage citizens/patients in clinical research, there are still obstacles to participation. Among the main discouraging aspects are incomplete understanding of the concepts related to a clinical trial, and the scant, sometimes confused, explanations given. This observational, cross-sectional multicenter study investigated knowledge, attitudes and trust in clinical research. We conducted a survey among women with ovarian cancer at their first follow-up visit or first therapy session, treated in centers belonging to the Mario Negri Gynecologic Oncology (MaNGO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups. A questionnaire on knowledge, attitudes and experience was assembled ad hoc after a literature review and a validation process involving patients of the Alliance against Ovarian Cancer (ACTO). Results From 25 centers 348 questionnaire were collected; 73.5% of responders were 56 years or older, 54.8% had a high level of education, more than 80% had no experience of trial participation. Among participants 59% knew what clinical trials were and 71% what informed consent was. However, more than half did not know the meaning of the term randomization. More than half (56%) were in favor of participating in a clinical trial, but 35% were not certain. Almost all responders acknowledged the doctor’s importance in decision-making. Patients’ associations were recognized as having a powerful role in the design and planning of clinical trials. Conclusions This study helps depict the knowledge and attitudes of women with ovarian cancer in relation to clinical trials, suggesting measures aimed at improving trial “culture”, literacy and compliance, and fresh ways of communication between doctors and patients. Supplementary Information The online version contains supplementary material available at 10.1186/s13048-022-00970-w.
Collapse
|
8
|
Bongiorno G, Bosco A, Bianchi R, Rinaldi L, Foglia Manzillo V, Gizzarelli M, Maurelli MP, Giaquinto D, El Houda Ben Fayala N, Varloud M, Crippa A, Oliva G, Gradoni L, Cringoli G. Laboratory evidence that dinotefuran, pyriproxyfen and permethrin combination abrogates Leishmania infantum transmissibility by sick dogs. Med Vet Entomol 2022; 36:81-87. [PMID: 34724230 PMCID: PMC9298322 DOI: 10.1111/mve.12553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/22/2021] [Revised: 10/05/2021] [Accepted: 10/14/2021] [Indexed: 06/13/2023]
Abstract
Dogs are reservoir hosts of leishmaniasis caused by Leishmania infantum and transmitted by phlebotomine vectors. The effect of dinotefuran, pyriproxyfen and permethrin spot-on solution (Vectra®3D, Ceva Santé Animale, Libourne, France) on Leishmania transmissibility by naturally infected dogs via reared Phlebotomus perniciosus, was assessed. Dogs affected by leishmaniasis were submitted to xenodiagnosis and 6 infecting >10% of insects were treated topically on day 0. Antifeeding, insecticidal and anti-transmissibility effects were evaluated through xenodiagnoses performed on days 1, 7 and 28, using individual pre-treatment parameters as control. Feeding and mortality rates were assessed at 24 h, whereas promastigote infection, maturation and burden were assessed up to 96 h post blood meal (potentially infectious rate). On day 1, the anti-feeding efficacy was >95% in 4 dogs, insecticidal efficacy 100% in 4 dogs, and anti-transmissibility effect 100% in 6 dogs. Efficacy rates recorded on day 7 were very similar to day 1. On day 28, anti-feeding and insecticidal efficacy values were much broader, ranging 32.6-100% and 7.7-94.4%, respectively. Potentially infectious insects were recorded from two dogs, with sharp decrease in transmissibility rate as compared with pre-treatment condition. Altogether, Vectra®3D abrogated by >98% the potential Leishmania transmissibility by the examined pool of infected dogs over 1 month.
Collapse
Affiliation(s)
- G. Bongiorno
- Unit of Vector‐borne DiseasesIstituto Superiore di SanitàRomeItaly
| | - A. Bosco
- Department of Veterinary Medicine and Animal ProductionUniversity of Naples Federico IINaplesItaly
- CREMOPAREboliItaly
| | - R. Bianchi
- Unit of Vector‐borne DiseasesIstituto Superiore di SanitàRomeItaly
| | - L. Rinaldi
- Department of Veterinary Medicine and Animal ProductionUniversity of Naples Federico IINaplesItaly
- CREMOPAREboliItaly
| | - V. Foglia Manzillo
- Department of Veterinary Medicine and Animal ProductionUniversity of Naples Federico IINaplesItaly
| | - M. Gizzarelli
- Department of Veterinary Medicine and Animal ProductionUniversity of Naples Federico IINaplesItaly
| | - M. P. Maurelli
- Department of Veterinary Medicine and Animal ProductionUniversity of Naples Federico IINaplesItaly
- CREMOPAREboliItaly
| | - D. Giaquinto
- Department of Veterinary Medicine and Animal ProductionUniversity of Naples Federico IINaplesItaly
| | - N. El Houda Ben Fayala
- Department of Veterinary Medicine and Animal ProductionUniversity of Naples Federico IINaplesItaly
| | | | | | - G. Oliva
- Department of Veterinary Medicine and Animal ProductionUniversity of Naples Federico IINaplesItaly
| | - L. Gradoni
- Unit of Vector‐borne DiseasesIstituto Superiore di SanitàRomeItaly
| | - G. Cringoli
- Department of Veterinary Medicine and Animal ProductionUniversity of Naples Federico IINaplesItaly
- CREMOPAREboliItaly
| |
Collapse
|
9
|
Magli MC, Albanese C, Crippa A, Terzuoli G, La Sala G, Tabanelli C, Gianaroli L. Permanence of de novo segmental aneuploidy in sequential embryo biopsies. Hum Reprod 2021; 35:759-769. [PMID: 32242613 DOI: 10.1093/humrep/deaa025] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2019] [Revised: 01/27/2020] [Indexed: 12/22/2022] Open
Abstract
STUDY QUESTION Is de novo segmental aneuploidy (SA) a biological event or an artifact that is erroneously interpreted as partial chromosome imbalance? SUMMARY ANSWER The detection of de novo SA in sequential biopsies of preimplantation embryos supports the biological nature of SA. WHAT IS KNOWN ALREADY Although some SAs are detected in oocytes and in blastocysts, the highest incidence is observed in cleavage-stage embryos. Based on these findings, we can postulate that the majority of cells affected by SAs are eliminated by apoptosis or that affected embryos mainly undergo developmental arrest. STUDY DESIGN, SIZE, DURATION This retrospective study includes 342 preimplantation genetic testing for aneuploidy (PGT-A) cycles performed between January 2014 and December 2018. Chromosome analysis was performed on 331 oocytes, 886 cleavage-stage embryos and 570 blastocysts (n = 1787). From 268 expanded blastocysts, the blastocoelic fluid (BF) was also analyzed (resulting in 2025 samples in total). In cases of SAs involving loss or gain in excess of 15 Mb, embryos were not considered for transfer and sequential biopsies were performed at following stages. This resulted in 66 sets where the initial diagnosis of SAs (4 made in polar bodies, 25 in blastomeres and 37 in trophectoderm (TE) cells) was followed up. PARTICIPANTS/MATERIALS, SETTING, METHODS A total of 2082 samples (2025 + 27 whole embryos) were processed by whole genome amplification followed by array comparative genomic hybridization. MAIN RESULTS AND THE ROLE OF CHANCE The incidence of SAs was 6.3% in oocytes, increased to 16.6% in cleavage-stage embryos (P < 0.001) and decreased to 11.2% in blastocysts (P < 0.025 versus oocytes; P < 0.01 versus cleavage-stage embryos). The highest incidence of SAs was found in BFs (26.1%, P < 0.001). The analysis of 66 sets of sequential biopsies revealed that the initial finding was confirmed in all following samples from 39 sets (59.1% full concordance). In 12 additional sets, SAs were detected in some samples while in others the interested chromosome had full aneuploidy (18.2%). In three more sets, there was a partial concordance with the initial diagnosis in some samples, but in all TE samples the interested chromosome was clearly euploid (4.5%). In the remaining 12 sets, the initial SA was not confirmed at any stage and the corresponding chromosomes were euploid (18.2% no concordance). The pattern of concordance was not affected by the number of SAs in the original biopsy (single, double or complex) or by the absence or presence of concomitant aneuploidies for full chromosomes. LIMITATIONS, REASONS FOR CAUTION Chromosome analyses were performed on biopsies that might not be representative of the true constitution of the embryo itself due to the occurrence of mosaicism. WIDER IMPLICATIONS OF THE FINDINGS The permanence of SAs throughout the following stages of embryo development in more than half of the analyzed sets suggests for this dataset a very early origin of this type of chromosome imbalance, either at meiosis or at the first mitotic divisions. Since SAs remained in full concordance with the initial diagnosis until the blastocyst stage, a corrective mechanism seems not to be in place. In the remaining cases, it is likely that, as for full chromosome aneuploidy, mosaicism derived from mitotic errors could have occurred. In following cell divisions, euploid cell lines could prevail preserving the embryo chances of implantation. Due to the scarcity of data available, the transfer of embryos with SAs should be strictly followed up to establish possible clinical consequences related to this condition. STUDY FUNDING/COMPETING INTEREST(S) No specific funding was obtained. There are no conflicts of interest.
Collapse
Affiliation(s)
- M C Magli
- Società Italiana Studi Medicina della Riproduzione, Reproductive Medicine Unit, S.I.S.Me.R., Bologna, Italy
| | - C Albanese
- Società Italiana Studi Medicina della Riproduzione, Reproductive Medicine Unit, S.I.S.Me.R., Bologna, Italy
| | - A Crippa
- Società Italiana Studi Medicina della Riproduzione, Reproductive Medicine Unit, S.I.S.Me.R., Bologna, Italy
| | - G Terzuoli
- Società Italiana Studi Medicina della Riproduzione, Reproductive Medicine Unit, S.I.S.Me.R., Bologna, Italy
| | - G La Sala
- Società Italiana Studi Medicina della Riproduzione, Reproductive Medicine Unit, S.I.S.Me.R., Bologna, Italy
| | - C Tabanelli
- Società Italiana Studi Medicina della Riproduzione, Reproductive Medicine Unit, S.I.S.Me.R., Bologna, Italy
| | - L Gianaroli
- Società Italiana Studi Medicina della Riproduzione, Reproductive Medicine Unit, S.I.S.Me.R., Bologna, Italy
| |
Collapse
|
10
|
Lindberg J, De Laere B, Crippa A, Eklund M, Grönberg H. ProBio: An outcome-adaptive, multi-arm, open-label, multiple assignment randomised controlled biomarker-driven trial in patients with metastatic castration-resistant prostate cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz248.053] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
11
|
De Laere B, Crippa A, Ghysel C, Ost P, Rajan P, Eklund M, Dirix L, Grönberg H, Lindberg J. Elevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz239.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
12
|
Albanese C, Magli M, Crippa A, Benincasa M, Ferraretti A, Tabanelli C, Gianaroli L. 53. MEAN NUMBER OF ANALYZED EMBRYOS IN PGT-M CYCLES TO UNDERGO AT LEAST ONE EMBRYO TRANSFER. Reprod Biomed Online 2019. [DOI: 10.1016/j.rbmo.2019.04.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
13
|
Crippa A, Ezzouch R, Aprá A, Amisse A, Laviéville R, Hutin L, Bertrand B, Vinet M, Urdampilleta M, Meunier T, Sanquer M, Jehl X, Maurand R, De Franceschi S. Gate-reflectometry dispersive readout and coherent control of a spin qubit in silicon. Nat Commun 2019; 10:2776. [PMID: 31270319 PMCID: PMC6610084 DOI: 10.1038/s41467-019-10848-z] [Citation(s) in RCA: 55] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2018] [Accepted: 05/22/2019] [Indexed: 11/11/2022] Open
Abstract
Silicon spin qubits have emerged as a promising path to large-scale quantum processors. In this prospect, the development of scalable qubit readout schemes involving a minimal device overhead is a compelling step. Here we report the implementation of gate-coupled rf reflectometry for the dispersive readout of a fully functional spin qubit device. We use a p-type double-gate transistor made using industry-standard silicon technology. The first gate confines a hole quantum dot encoding the spin qubit, the second one a helper dot enabling readout. The qubit state is measured through the phase response of a lumped-element resonator to spin-selective interdot tunneling. The demonstrated qubit readout scheme requires no coupling to a Fermi reservoir, thereby offering a compact and potentially scalable solution whose operation may be extended above 1 K.
Collapse
Affiliation(s)
- A Crippa
- CEA, INAC-PHELIQS, University of Grenoble Alpes, F-38000, Grenoble, France.
| | - R Ezzouch
- CEA, INAC-PHELIQS, University of Grenoble Alpes, F-38000, Grenoble, France
| | - A Aprá
- CEA, INAC-PHELIQS, University of Grenoble Alpes, F-38000, Grenoble, France
| | - A Amisse
- CEA, INAC-PHELIQS, University of Grenoble Alpes, F-38000, Grenoble, France
| | - R Laviéville
- CEA, LETI, Minatec Campus, F-38000, Grenoble, France
| | - L Hutin
- CEA, LETI, Minatec Campus, F-38000, Grenoble, France
| | - B Bertrand
- CEA, LETI, Minatec Campus, F-38000, Grenoble, France
| | - M Vinet
- CEA, LETI, Minatec Campus, F-38000, Grenoble, France
| | - M Urdampilleta
- CNRS, Grenoble INP, Institut Néel, University of Grenoble Alpes, F-38000, Grenoble, France
| | - T Meunier
- CNRS, Grenoble INP, Institut Néel, University of Grenoble Alpes, F-38000, Grenoble, France
| | - M Sanquer
- CEA, INAC-PHELIQS, University of Grenoble Alpes, F-38000, Grenoble, France
| | - X Jehl
- CEA, INAC-PHELIQS, University of Grenoble Alpes, F-38000, Grenoble, France
| | - R Maurand
- CEA, INAC-PHELIQS, University of Grenoble Alpes, F-38000, Grenoble, France.
| | - S De Franceschi
- CEA, INAC-PHELIQS, University of Grenoble Alpes, F-38000, Grenoble, France
| |
Collapse
|
14
|
Abstract
Se investigó en 32 especies fúngicas, la producción de enzimas extracelulares y ms determinaciones cualitativas (amilasa, celulosa, caseinasa, fosfatasa, lipasa, pectinasa y ureasa). La detección de los enzimas en los cultivos fúngicos en agar varió ampliamente.En la mayoría de los cultivos fúngicos se detectaron: amilasas, ureasas, y fosfatasas. Las celulosas se pesquizaron particularmente en cultivo de Aspergillus flavus, A. fumigatus, Cladosporium cladosporioides Penicillium brevicompactum, Rhizopus stolonifer, Scopulariopsis flava y Trichothecium roseum. Penicillium digitatum y P.duclauxi fueron productores de caseinasa en un alto grado. La actividad lipolítica se detectó en cultivos con grasas sintéticas tweens 20, 40, 60, y 80 como sustrato para lipasa. Indicaron actividad lipolítico para estos sustratos A. flavus, Aureobasidium pullulans, C. cladosporioides, Gliocladium roseum, Mycothypha microspora, Microsporum gypseum, P. brevicompactum y Scopulariopsis brumptii. Productores de pectinasas fueron las cepas de A. flavus, C. cladosporioides y Fusarium oxysporum, P. brevicompoctum y Ulocladium atrum
Collapse
|
15
|
Mariani L, Formelli F, De Palo G, Manzari A, Camerini T, Campa T, Di Mauro MG, Crippa A, Delle Grottaglie M, Del Vecchio M, Marubini E, Costa A, Veronesi U. Chemoprevention of Breast Cancer with Fenretinide (4-HPR): Study of Long-Term Visual and Ophthalmologic Tolerability. Tumori 2018; 82:444-9. [PMID: 9063520 DOI: 10.1177/030089169608200506] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Background Fenretinide (4-HPR) is a synthetic retinoid being clinically tested in the chemoprevention of different tumors and precancerous lesions. Though safer than many other retinoids in experimental models, in humans 4-HPR may induce adverse effects that mainly affect the eye and visual function. Such effects are thought to be caused by the reduction of plasma retinol levels, which occurs after administration of the retinoid. Methods A series of 826 women treated with 4-HPR was studied to quantify the incidence and temporal pattern of occurrence of visual (dark adaptation) and ophthalmologic complaints (ocular dryness, lacrimation, conjunctivitis or photophobia) and to investigate the possible association between their occurrence and plasma retinol levels. Results The cumulative incidence of visual complaints reached nearly 20% at 5 years. The occurrence of these symptoms was more frequent at the start of treatment. The probability of developing visual complaints was significantly higher in patients with lower plasma retinol concentrations following 4-HPR treatment. The cumulative incidence of ophthalmologic complaints was 8% at 5 years. The occurrence of these complaints was evenly distributed during treatment. Ophthalmologic complaints were not associated with a greater degree of reduction of plasma retinol concentrations, but rather with the patient's age, since symptomatic patients were generally older than asymptomatic patients. Conclusions Visual and ophthalmologic complaints are common during 4-HPR treatment: their estimated 5-year cumulative incidence is close to 20% and 8%, respectively. However, the pattern of occurrence over time and the underlying mechanisms of these two types of complaints seem different.
Collapse
Affiliation(s)
- L Mariani
- Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Crippa A, Orsini N. Avoid exclusion of studies in synthesis of dose-response data using a novel one-stage approach. Eur J Public Health 2017. [DOI: 10.1093/eurpub/ckx187.235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- A Crippa
- Karolinska Institutet, Stockholm, Sweden
| | - N Orsini
- Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
17
|
Villa F, Colombo I, Crippa A, De Martini G, Lafranconi M, Dell'Oro S, Vittimberga I, Arnoffi J, Guida F, Villa S, Anghilieri M, Viganò C, Ferrando P, De Nittis G, Valsecchi V, Ardizzoia A. Sharing long term follow-up of breast cancer survivors with family physician: a province of Lecco experience. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
18
|
Buoro S, Mecca T, Seghezzi M, Manenti B, Azzarà G, Dominoni P, Crippa A, Ottomano C, Lippi G. Analytical comparison between two hematological analyzer systems: CAL-8000vs. XN-9000. Int J Lab Hematol 2016; 39:147-162. [DOI: 10.1111/ijlh.12597] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2016] [Accepted: 09/14/2016] [Indexed: 11/27/2022]
Affiliation(s)
- S. Buoro
- Clinical Chemistry Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | - T. Mecca
- Clinical Chemistry Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | - M. Seghezzi
- Clinical Chemistry Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | - B. Manenti
- Clinical Chemistry Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | | | - P. Dominoni
- Clinical Chemistry Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | - A. Crippa
- Clinical Chemistry Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | | | - G. Lippi
- Section of Clinical Biochemistry; University of Verona; Verona Italy
| |
Collapse
|
19
|
Fiocchi R, D'Elia E, Vittori C, Sebastiani R, Strobelt N, Eleftheriou G, Introna M, Freddi C, Crippa A. First Report of a Successful Pregnancy in an Everolimus-Treated Heart-Transplanted Patient: Neonatal Disappearance of Immunosuppressive Drugs. Am J Transplant 2016; 16:1319-22. [PMID: 26555407 DOI: 10.1111/ajt.13514] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2015] [Revised: 08/27/2015] [Accepted: 08/29/2015] [Indexed: 01/25/2023]
Abstract
The use of everolimus (EVL) as primary immunosuppression is steadily increasing in heart transplantation (HTx) patients. Limited data currently exist in kidney transplantation, but there is no report of EVL use during pregnancy after HTx and its pharmacokinetics in the newborn. We report a case of an unplanned pregnancy discovered at 21 weeks of gestation in a female HTx patient aged 40 years treated with EVL and cyclosporine (CyA). Because pregnancy was advanced, immunosuppression therapy was left unchanged. At 36 weeks, a healthy infant was delivered. At birth, CyA blood levels were lower in the neonate, but EVL concentrations in maternal and neonatal umbilical blood were similar. Amniotic fluid concentrations were undetectable for both drugs. In the newborn, EVL was measurable at 5 days after birth, whereas CyA disappeared within 2 days. Cord blood displayed a normal count of B and T cells and CD4, CD8 and natural killer cell populations. At birth, both mother and newborn displayed the same blood levels of EVL; therefore, a filter effect of the placenta may be hypothesized for CyA but not for EVL. No immediate complications were observed with this pregnancy.
Collapse
Affiliation(s)
- R Fiocchi
- Cardiovascular Department, Hospital Papa Giovanni XXIII, Bergamo, Italy
| | - E D'Elia
- Cardiovascular Department, Hospital Papa Giovanni XXIII, Bergamo, Italy
| | - C Vittori
- Cardiovascular Department, Hospital Papa Giovanni XXIII, Bergamo, Italy
| | - R Sebastiani
- Cardiovascular Department, Hospital Papa Giovanni XXIII, Bergamo, Italy
| | - N Strobelt
- Gynecology and Obstetrics Department, Hospital Papa Giovanni XXIII, Bergamo, Italy
| | - G Eleftheriou
- Teratology Information Service, Hospital Papa Giovanni XXIII, Bergamo, Italy
| | - M Introna
- Hematology Department, Hospital Papa Giovanni XXIII, Bergamo, Italy
| | - C Freddi
- Laboratory Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy
| | - A Crippa
- Laboratory Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy
| |
Collapse
|
20
|
Crippa A, Discacciati A, Orsini N, Oskarsson V. Letter: coffee consumption and gallstone disease - a cautionary note on the assignment of exposure values in dose-response meta-analyses. Aliment Pharmacol Ther 2016; 43:166-7. [PMID: 26638932 DOI: 10.1111/apt.13428] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/08/2022]
Affiliation(s)
- A Crippa
- Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - A Discacciati
- Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - N Orsini
- Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - V Oskarsson
- Unit of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
| |
Collapse
|
21
|
Brambati C, Galbiati S, Xue E, Toffalori C, Crucitti L, Greco R, Sala E, Crippa A, Chiesa L, Soriani N, Mazzi B, Tresoldi C, Stanghellini MTL, Peccatori J, Carrabba MG, Bernardi M, Ferrari M, Lampasona V, Ciceri F, Vago L. Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation. Haematologica 2015; 101:e157-61. [PMID: 26703962 DOI: 10.3324/haematol.2015.135467] [Citation(s) in RCA: 48] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Affiliation(s)
- Chiara Brambati
- Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Silvia Galbiati
- Genomics for the Diagnosis of Human Pathologies Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Elisabetta Xue
- Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy. Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Cristina Toffalori
- Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Lara Crucitti
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Raffaella Greco
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Elisa Sala
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Alessandra Crippa
- Molecular Hematology Laboratory, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Lorenza Chiesa
- Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Nadia Soriani
- Genomics for the Diagnosis of Human Pathologies Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Benedetta Mazzi
- Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Cristina Tresoldi
- Molecular Hematology Laboratory, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | | | - Jacopo Peccatori
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Matteo G Carrabba
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Massimo Bernardi
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Maurizio Ferrari
- Genomics for the Diagnosis of Human Pathologies Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Vito Lampasona
- Genomics for the Diagnosis of Human Pathologies Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - Fabio Ciceri
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy.
| | - Luca Vago
- Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy. Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| |
Collapse
|
22
|
Xue E, Tresoldi C, Sala E, Crippa A, Mazzi B, Greco R, Messina C, Carrabba MG, Lupo Stanghellini MT, Marktel S, Corti C, Peccatori J, Bernardi M, Ciceri F, Vago L. Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse. Bone Marrow Transplant 2015; 51:466-9. [PMID: 26642331 DOI: 10.1038/bmt.2015.296] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- E Xue
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy.,Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - C Tresoldi
- Molecular Hematology Laboratory, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - E Sala
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - A Crippa
- Molecular Hematology Laboratory, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - B Mazzi
- Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - R Greco
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - C Messina
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - M G Carrabba
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - M T Lupo Stanghellini
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - S Marktel
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - C Corti
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - J Peccatori
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - M Bernardi
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - F Ciceri
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy
| | - L Vago
- Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy.,Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy
| |
Collapse
|
23
|
Buoro S, Mecca T, Azzarà G, Seghezzi M, Candiago E, Gianatti A, Crippa A, La Gioia A. Mindray BC-6800 body fluid mode, performance of nucleated cells, and differential count in ascitic and pleural fluids. Int J Lab Hematol 2015; 38:90-101. [DOI: 10.1111/ijlh.12446] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2015] [Accepted: 09/22/2015] [Indexed: 11/26/2022]
Affiliation(s)
- S. Buoro
- Chimical Chemistry Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | - T. Mecca
- Chimical Chemistry Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | - G. Azzarà
- Chimical Chemistry Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | - M. Seghezzi
- Chimical Chemistry Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | - E. Candiago
- Pathology Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | - A. Gianatti
- Pathology Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | - A. Crippa
- Chimical Chemistry Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| | - A. La Gioia
- Chimical Chemistry Laboratory; Hospital Papa Giovanni XXIII; Bergamo Italy
| |
Collapse
|
24
|
Orlando G, Tanzi E, Fasolo M, Bianchi S, Mazza F, Frati E, Crippa A, Martinelli M, Rizzardini G, Gramegna M. Cervical cancer screening for high-risk women? Data from a multicenter study in Lombardy – Italy. Eur J Public Health 2015. [DOI: 10.1093/eurpub/ckv175.214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
25
|
Maddalo D, Manchado E, Concepcion CP, Bonetti C, Vidigal JA, Han YC, Ogrodowski P, Crippa A, Rekhtman N, de Stanchina E, Lowe SW, Ventura A. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature 2014; 516:423-7. [PMID: 25337876 PMCID: PMC4270925 DOI: 10.1038/nature13902] [Citation(s) in RCA: 433] [Impact Index Per Article: 43.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2014] [Accepted: 09/30/2014] [Indexed: 12/24/2022]
Abstract
Chromosomal rearrangements play a central role in the pathogenesis of human cancers and often result in the expression of therapeutically actionable gene fusions1. A recently discovered example is a fusion between the Echinoderm Microtubule-associated Protein-like 4 (EML4) and the Anaplastic Lymphoma Kinase (ALK) genes, generated by an inversion on the short arm of chromosome 2: inv(2)(p21p23). The EML4-ALK oncogene is detected in a subset of human non-small cell lung cancers (NSCLC)2 and is clinically relevant because it confers sensitivity to ALK inhibitors3. Despite their importance, modeling such genetic events in mice has proven challenging and requires complex manipulation of the germline. Here we describe an efficient method to induce specific chromosomal rearrangements in vivo using viral-mediated delivery of the CRISPR/Cas9 system to somatic cells of adult animals. We apply it to generate a mouse model of Eml4-Alk-driven lung cancer. The resulting tumors invariably harbor the Eml4-Alkinversion, express the Eml4-Alk fusion gene, display histo-pathologic and molecular features typical of ALK+ human NSCLCs, and respond to treatment with ALK-inhibitors. The general strategy described here substantially expands our ability to model human cancers in mice and potentially in other organisms.
Collapse
Affiliation(s)
- Danilo Maddalo
- Memorial Sloan Kettering Cancer Center, Cancer Biology and Genetics Program, 1275 York Avenue, New York, New York 10065, USA
| | - Eusebio Manchado
- Memorial Sloan Kettering Cancer Center, Cancer Biology and Genetics Program, 1275 York Avenue, New York, New York 10065, USA
| | - Carla P Concepcion
- 1] Memorial Sloan Kettering Cancer Center, Cancer Biology and Genetics Program, 1275 York Avenue, New York, New York 10065, USA [2] Weill Cornell Graduate School of Medical Sciences of Cornell University, 1300 York Avenue, New York, New York 10065, USA
| | - Ciro Bonetti
- Memorial Sloan Kettering Cancer Center, Cancer Biology and Genetics Program, 1275 York Avenue, New York, New York 10065, USA
| | - Joana A Vidigal
- Memorial Sloan Kettering Cancer Center, Cancer Biology and Genetics Program, 1275 York Avenue, New York, New York 10065, USA
| | - Yoon-Chi Han
- Memorial Sloan Kettering Cancer Center, Cancer Biology and Genetics Program, 1275 York Avenue, New York, New York 10065, USA
| | - Paul Ogrodowski
- Memorial Sloan Kettering Cancer Center, Cancer Biology and Genetics Program, 1275 York Avenue, New York, New York 10065, USA
| | - Alessandra Crippa
- Milano-Bicocca University, Department of Medical Oncology, San Gerardo Hospital, 20052, Via G B Pergolesi 33, Monza, Italy
| | - Natasha Rekhtman
- Memorial Sloan Kettering Cancer Center, Thoracic Pathology and Cytopathology, 1275 York Avenue, New York, New York 10065, USA
| | - Elisa de Stanchina
- Memorial Sloan Kettering Cancer Center, Molecular Pharmacology Program, 1275 York Avenue, New York, New York 10065, USA
| | - Scott W Lowe
- 1] Memorial Sloan Kettering Cancer Center, Cancer Biology and Genetics Program, 1275 York Avenue, New York, New York 10065, USA [2] Howard Hughes Medical Institute, 1275 York Avenue, New York, New York 10065, USA
| | - Andrea Ventura
- Memorial Sloan Kettering Cancer Center, Cancer Biology and Genetics Program, 1275 York Avenue, New York, New York 10065, USA
| |
Collapse
|
26
|
Kilani Z, Magli MC, Qaddomi E, Ferraretti AP, Shaban M, Crippa A, Haj Hassan L, Shenfield F, Gianaroli L. Chromosome analysis in embryos from young patients with previous parity. Reprod Biomed Online 2014; 29:333-9. [DOI: 10.1016/j.rbmo.2014.04.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2013] [Revised: 04/23/2014] [Accepted: 04/24/2014] [Indexed: 11/26/2022]
|
27
|
Messina C, Candoni A, Carrabba MG, Tresoldi C, Sala E, Tassara M, Crippa A, Peccatori J, Assanelli A, Gattillo S, Bellio L, Fanin R, Ciceri F, Bernardi M. Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia. Biol Blood Marrow Transplant 2014; 20:1586-91. [PMID: 24954546 DOI: 10.1016/j.bbmt.2014.06.017] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2014] [Accepted: 06/11/2014] [Indexed: 10/25/2022]
Abstract
Autologous hematopoietic stem cell transplantation (ASCT) is a curative option alternative to allogeneic transplantation for patients with acute myeloid leukemia (AML). Relapse after ASCT can be due to contamination with leukemic blasts of autologous peripheral blood stem cells (PBSCs) collected by leukapheresis (LK). Identification and quantification of a minimal residual disease (MRD) marker in PBSCs could be relevant in determining the relapse risk after ASCT. High levels of the WT1 gene transcript in bone marrow of AML patients after treatment completion predict disease relapse. We evaluated WT1 transcript levels in autologous PBSC from LK used for ASCT in 30 consecutive AML patients in complete remission (CR) and established a correlation with clinical outcome. At diagnosis, all patients had WT1 overexpression. All patients were in morphological and genetic CR at the time of PBSC collection and before ASCT. Real-time quantitative PCR of WT1 was performed in samples of each LK, using TaqMan technology on RNA from mononucleated cells. The median WT1 transcript level in the PBSC graft (WT1-LK) of patients who relapsed was significantly higher than of those who did not relapse after transplantation (P <.0001). We defined a cut-off level of 80 WT1-LK copies/ABL 10e4 copies to discriminate between positive and negative PBSC grafts. The cut-off level was strongly associated with disease recurrence, DFS and OS. Our study represents the largest series of patients evaluating WT1 as a marker of MRD in PBSC LK products using a completely standardized real-time WT1-reverse transcriptase-PCR based assay. These data, if confirmed by prospective study, will help to determine an individual patient's adapted postremission allocation strategy.
Collapse
Affiliation(s)
- Carlo Messina
- Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
| | - Anna Candoni
- Division of Hematology and Bone Marrow Transplantation Unit, University Hospital of Udine, Udine, Italy
| | - Matteo G Carrabba
- Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
| | - Cristina Tresoldi
- Immuno-hematology and Transfusion Medicine, San Raffaele Scientific Institute, Milan, Italy
| | - Elisa Sala
- Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
| | - Michela Tassara
- Immuno-hematology and Transfusion Medicine, San Raffaele Scientific Institute, Milan, Italy
| | - Alessandra Crippa
- Immuno-hematology and Transfusion Medicine, San Raffaele Scientific Institute, Milan, Italy
| | - Jacopo Peccatori
- Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
| | - Andrea Assanelli
- Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
| | - Salvatore Gattillo
- Immuno-hematology and Transfusion Medicine, San Raffaele Scientific Institute, Milan, Italy
| | - Laura Bellio
- Immuno-hematology and Transfusion Medicine, San Raffaele Scientific Institute, Milan, Italy
| | - Renato Fanin
- Division of Hematology and Bone Marrow Transplantation Unit, University Hospital of Udine, Udine, Italy
| | - Fabio Ciceri
- Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
| | - Massimo Bernardi
- Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
| |
Collapse
|
28
|
Cereda E, Codullo V, Klersy C, Breda S, Crippa A, Rava M, Orlandi M, Bonardi C, Quarleri L, Cappello S, Caporali R, Caccialanza R. PP115-MON SERUM PREALBUMIN IS A PREDICTOR OF MORTALITY IN SYSTEMIC SCLEROSIS OUTPATIENTS. Clin Nutr 2013. [DOI: 10.1016/s0261-5614(13)60426-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
29
|
Cereda E, Codullo V, Klersy C, Breda S, Crippa A, Rava M, Orlandi M, Bonardi C, Quarleri L, Cappello S, Caporali R, Caccialanza R. PP131-SUN DISEASE-RELATED NUTRITIONAL RISK AND MORTALITY IN SYSTEMIC SCLEROSIS. Clin Nutr 2013. [DOI: 10.1016/s0261-5614(13)60176-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
30
|
Hu JCY, Seo BK, Neri QV, Rozenwaks Z, Palermo GD, Fields T, Neri QV, Monahan D, Rosenwaks Z, Palermo GD, Szkodziak P, Plewka K, Wozniak S, Czuczwar P, Mroczkowski A, Lorenzo Leon C, Hernandez J, Chinea Mendez E, Concepcion Lorenzo C, Sanabria Perez V, Puopolo M, Palumbo A, Toth B, Franz C, Montag M, Boing A, Strowitzki T, Nieuwland R, Griesinger G, Schultze-Mosgau A, Cordes T, Depenbusch M, Diedrich K, Vloeberghs V, Verheyen G, Camus M, Van de Velde H, Goossens A, Tournaye H, Coppola G, Di Caprio G, Wilding M, Ferraro P, Esposito G, Di Matteo L, Dale R, Coppola G, Dale B, Daoud S, Auger J, Wolf JP, Dulioust E, Lafuente R, Lopez G, Brassesco M, Hamad M, Montenarh M, Hammadeh M, Robles F, Magli MC, Crippa A, Pescatori E, Ferraretti AP, Gianaroli L, Zahiri M, Movahedin M, Mowla SJ, Noruzinia M, Crippa A, Ferraretti AP, Magli MC, Crivello AM, Robles F, Gianaroli L, Sermondade N, Dupont C, Hafhouf E, Cedrin-Durnerin I, Poncelet C, Benzacken B, Levy R, Sifer C, Ferfouri F, Boitrelle F, Clement P, Molina Gomes D, Bailly M, Selva J, Vialard F, Yaprak E, Basar M, Guzel E, Arda O, Irez T, Norambuena P, Krenkova P, Tuettelmann F, Kliesch S, Paulasova P, Stambergova A, Macek M, Macek M, Rivera R, Garrido-Gomez T, Galletero S, Meseguer M, Dominguez F, Garrido N, Mallidis C, Sanchez V, Weigeng L, Redmann K, Wistuba J, Gross P, Wuebbelling F, Fallnich C, Burger M, Kliesch S, Schlatt S, San Celestino Carchenilla M, Pacheco Castro A, Simon Sanjurjo P, Molinero Ballesteros A, Rubio Garcia S, Garcia Velasco JA, Macanovic B, Otasevic V, Korac A, Vucetic M, Garalejic E, Ivanovic Burmazovic I, Filipovic MR, Buzadzic B, Stancic A, Jankovic A, Velickovic K, Golic I, Markelic M, Korac B, Gosalvez J, Ruiz-Jorro M, Garcia-Ochoa C, Sachez-Martin P, Martinez-Moya M, Caballero P, Hasegawa N, Fukunaga N, Nagai R, Kitasaka H, Yoshimura T, Tamura F, Kato M, Nakayama K, Oono H, Kojima E, Yasue K, Watanabe H, Asano E, Hashiba Y, Asada Y, Das M, Al-Hathal N, San-Gabriel M, Phillips S, Kadoch IJ, Bissonnette F, Holzer H, Zini A, Zebitay AG, Irez T, Ocal P, Sahmay S, Karahuseyinoglu S, Usta T, Repping S, Silber S, Van Wely M, Datta A, Nayini K, Eapen A, Barlow S, Lockwood G, Tavares R, Baptista M, Publicover SJ, Ramalho-Santos J, Vaamonde D, Rodriguez I, Diaz A, Darr C, Chow V, Ma S, Smith R, Jeria F, Rivera J, Gabler F, Nicolai H, Cunha M, Viana P, Goncalves A, Silva J, Oliveira C, Teixeira da Silva J, Ferraz L, Madureira C, Doria S, Sousa M, Barros A, Herrero MB, Delbes G, Troueng E, Holzer H, Chan PTK, Vingris L, Setti AS, Braga DPAF, Figueira RCS, Iaconelli A, Borges E, Sargin Oruc A, Gulerman C, Zeyrek T, Yilmaz N, Tuzcuoglu D, Cicek N, Scarselli F, Terribile M, Franco G, Zavaglia D, Dente D, Zazzaro V, Riccio T, Minasi MG, Greco E, Cejudo-Roman A, Ravina CG, Candenas L, Gallardo-Castro M, Martin-Lozano D, Fernandez-Sanchez M, Pinto FM, Balasuriya A, Serhal P, Doshi A, Harper J, Romany L, Garrido N, Fernandez JL, Pellicer A, Meseguer M, Ribas-Maynou J, Garcia-Peiro A, Fernandez-Encinas A, Prada E, Jorda I, Cortes P, Llagostera M, Navarro J, Benet J, Kesici H, Cayli S, Erdemir F, Karaca Z, Aslan H, Karaca Z, Cayli S, Ocakli S, Kesici H, Erdemir F, Aslan H, Tas U, Ozdemir AA, Aktas RG, Tok OE, Ocakli S, Cayli S, Karaca Z, Erdemir F, Aslan H, Li S, Lu C, Hwu Y, Lee RK, Landaburu I, Gonzalvo MC, Clavero A, Ramirez JP, Pedrinaci S, Serrano M, Montero L, Carrillo S, Weiss J, Ortiz AP, Castilla JA, Sahin O, Bakircioglu E, Serdarogullari M, Bayram A, Yayla S, Ulug U, Tosun SB, Bahceci M, Aktas RG, Ozdemir AA, Tok OE, Yoon SY, Shin DH, Shin TE, Park EA, Won HJ, Kim YS, Lee WS, Yoon TK, Lee DR, Hattori H, Nakajo Y, Kyoya T, Kuchiki M, Kanto S, Kyono K, Park M, Park MR, Lim EJ, Lee WS, Yoon TK, Lee DR, Choi Y, Mitra A, Bhattacharya J, Kundu A, Mukhopadhaya D, Pal M, Enciso M, Alfarawati S, Wells D, Fernandez-Encinas A, Garcia-Peiro A, Ribas-Maynou J, Abad C, Amengual MJ, Navarro J, Benet J, Esmaeili V, Safiri M, Shahverdi AH, Alizadeh AR, Ebrahimi B, Brucculeri AM, Ruvolo G, Giovannelli L, Schillaci R, Cittadini E, Scaravelli G, Perino A, Cortes Gallego S, Gabriel Segovia A, Nunez Calonge R, Guijarro Ponce A, Ortega Lopez L, Caballero Peregrin P, Heindryckx B, Kashir J, Jones C, Mounce G, Ramadan WM, Lemmon B, De Sutter P, Parrington J, Turner K, Child T, McVeigh E, Coward K, Bakircioglu E, Ulug U, Tosun S, Serdarogullari M, Bayram A, Ciray N, Bahceci M, Saeidi S, Shapouri F, Hoseinifar H, Sabbaghian M, Pacey A, Aflatoonian R, Bosco L, Ruvolo G, Carrillo L, Pane A, Manno M, Roccheri MC, Cittadini E, Selles E, Garcia-Herrero S, Martinez JA, Munoz M, Meseguer M, Garrido N, Durmaz A, Dikmen N, Gunduz C, Tavmergen Goker E, Tavmergen E, Gozuacik D, Vatansever HS, Kara B, Calimlioglu N, Yasar P, Tavmergen E, Tavmergen Goker E, Semerci B, Baka M, Ozbilgin K, Karabulut A, Tekin A, Sabah B, Cottin V, Kottelat D, Fellmann M, Halm S, Rosenthaler E, Kisida T, Kojima F, Sakamoto T, Makutina VA, Balezin SL, Rosly OF, Slishkina TV, Hatzi E, Lazaros L, Xita N, Makrydimas G, Sofikitis N, Kaponis A, Stefos T, Zikopoulos K, Georgiou I, Zikopoulos K, Lazaros L, Xita N, Makrydimas G, Sofikitis N, Kaponis A, Stefos T, Hatzi E, Georgiou I, Georgiou I, Lazaros L, Xita N, Makrydimas G, Sofikitis N, Kaponis A, Stefos T, Hatzi E, Zikopoulos K, Hibi H, Ohori T, Sumitomo M, Asada Y, Anarte C, Calvo I, Domingo A, Presilla N, Aleman M, Bou R, Guardiola F, Agirregoikoa JA, De Pablo JL, Barrenetxea G, Zhylkova I, Feskov O, Feskova I, Zozulina O, Somova O, Nabi A, Khalili MA, Roudbari F, Parmegiani L, Cognigni GE, Bernardi S, Taraborrelli S, Troilo E, Ciampaglia W, Pocognoli P, Infante FE, Tabarelli de fatis C, Arnone A, Maccarini AM, Filicori M, Silva L, Oliveira JBA, Petersen CG, Mauri AL, Massaro FC, Cavagna M, Baruffi RLR, Franco JG, Fujii Y, Endou Y, Mtoyama H, Shokri S, Aitken RJ. ANDROLOGY. Hum Reprod 2012. [DOI: 10.1093/humrep/27.s2.73] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
31
|
Dul EC, van Ravenswaaij-Arts CMA, Groen H, van Echten-Arends J, Land JA, Tyulenev Y, Naumenko V, Kurilo L, Shileiko L, Segal A, Klimova R, Kushch A, Ribas-Maynou J, Garcia-Peiro A, Abad C, Amengual MJ, Benet J, Navarro J, Colasante A, Lobascio AM, Scarselli F, Minasi MG, Alviggi E, Rubino P, Casciani V, Pena R, Varricchio MT, Litwicka K, Ferrero S, Zavaglia D, Franco G, Nagy ZP, Greco E, Romany L, Meseguer M, Garcia-Herrero S, Pellicer A, Garrido N, Dam A, Pijnenburg A, Hendriks JC, Westphal JR, Ramos L, Kremer JAM, Eertmans F, Bogaert V, Puype B, Geisler W, Clusmann C, Klopsch I, Strowitzki T, Eggert-Kruse W, Maettner R, Isachenko E, Isachenko V, Strehler E, Sterzik K, Band G, Madgar I, Brietbart H, Naor Z, Cunha-Filho JS, Souza CA, Krebs VG, Santos KD, Koff WJ, Stein A, Hammoud I, Albert M, Bergere M, Bailly M, Boitrelle F, Vialard F, Wainer R, Izard V, Selva J, Cohen - Bacrie P, Belloc S, de mouzon J, Cohen-Bacrie M, Alvarez S, Junca AM, Dumont M, Douard S, Prisant N, Tomita K, Hashimoto S, Akamatsu Y, Satoh M, Mori R, Inoue T, Ohnishi Y, Ito K, Nakaoka Y, Morimoto Y, Smith VJH, Ahuja KK, Atig F, Raffa M, Sfar MT, Saad A, Ajina M, Braga DPAF, Halpern G, Figueira RCS, Setti AS, Iaconelli Jr. A, Borges Jr. E, Medeiros GS, Borges Jr. E, Pasqualotto EB, Pasqualotto FF, Nadalini M, Tarozzi N, Di Santo M, Borini A, Lopez-Fernandez C, Arroyo F, Caballero P, Nunez-Calonge R, Fernandez JL, Gosalvez J, Gosalvez J, Lopez-Fernandez C, Gosalbez A, Cortes S, Caballero P, Nunez-Calonge R, Zikopoulos K, Lazaros L, Vartholomatos G, Kaponis A, Makrydimas G, Plachouras N, Sofikitis N, Kalantaridou S, Hatzi E, Georgiou I, Belloc S, de Mouzon J, Cohen-Bacrie M, Junca AM, Dumont M, Amar E, Cohen-Bacrie P, Vuillaume ML, Brugnon F, Artonne C, Janny L, Pons-Rejraji H, Fedder J, Bosco L, Ruvolo G, Bruccoleri AM, Manno M, Roccheri MC, Cittadini E, Bochev I, Gavrilov P, Kyurkchiev S, Shterev A, Carlomagno G, Colone M, Condorelli RA, Stringaro A, Calogero AE, Zakova J, Kralikova M, Crha I, Ventruba P, Melounova J, Matejovicova M, Vodova M, Lousova E, Sanchez Toledo M, Alvarez LLeo C, Garcia Garrido C, Resta Serra M, Belmonte Andujar LL, Gonzalez de Merlo G, Crha I, Zakova J, Ventruba P, Lousova E, Pohanka M, Huser M, Amiri I, Karimi J, Goodarzi MT, Tavilani H, Filannino A, Magli MC, Boudjema E, Crippa A, Ferraretti AP, Gianaroli L, Robles F, Magli MC, Crippa A, Filannino A, Ferraretti AP, Gianaroli L, Huang H, Yao DJ, Huang HJ, Li JR, Fan SK, Wang ML, Yung-Kuei S, Amer S, Mahran A, Darne J, Shaw R, Boudjema E, Magli MC, Borghi E, Cetera C, Ferraretti AP, Gianaroli L, Shukla U, Ogutu D, Deval B, Jansa M, Savvas M, Narvekar N, Houska P, Dackland AL, Bjorndahl L, Kvist U, Crippa A, Magli MC, Muzii L, Barboni B, Ferraretti AP, Gianaroli L, Samanta L, Kar S, Yakovenko SA, Troshina MN, Rutman BK, Dyakonov SA, Holmes E, Bjorndahl L, Kvist U, Feijo C, Verza Junior S, Esteves SC, Berta CL, Caille AM, Ghersevich SA, Zumoffen C, Munuce MJ, San Celestino M, Agudo D, Alonso M, Sanjurjo P, Becerra D, Bronet F, Garcia-Velasco JA, Pacheco A, Lafuente R, Lopez G, Checa MA, Carreras R, Brassesco M, Oneta M, Savasi V, Parrilla B, Guarneri D, Laureti A, Pagano F, Cetin I, Ekwurtzel E, Bjorndahl L, Kvist U, Morgante G, Piomboni P, Stendardi A, Serafini F, De Leo V, Focarelli R, Dumont M, Belloc S, Junca AM, Benkhalifa M, Cohen-Bacrie M, De Mouzon J, Entezami F, Cohen-Bacrie P, Junca A, Belloc S, Dumont M, Cohen-Bacrie M, Benkhalifa M, De Mouzon JJ, Entezami F, Cohen-Bacrie P, Mangiarini A, Capitanio E, Paffoni A, Restelli L, Guarneri C, Scarduelli C, Ragni G, Harrison K, Irving J, Martin N, Sherrin D, Yazdani A, Almeida C, Correia S, Rocha E, Alves A, Cunha M, Ferraz L, Silva S, Sousa M, Barros A, Perdrix A, Travers A, Milazzo JP, Clatot F, Mousset-Simeon N, Mace B, Rives N, Clarke HS, Callow A, Saxton D, Pacey AA, Sapir O, Oron G, Ben-Haroush A, Garor R, Feldberg D, Pinkas H, Stein A, Wertheimer A, Fisch B, Palacios E, Gonzalvo MC, Clavero A, Ramirez JP, Rosales A, Mozas J, Bjorndahl L, Castilla JA, Mugica J, Ramon O, Valdivia A, Exposito A, Casis L, Matorras R, Bongers R, Gottardo F, Zitzmann M, Kliesch S, Cordes T, Kamischke A, Schultze-Mosgau A, Buendgen N, Diedrich K, Griesinger G, Crisol L, Aspichueta F, Exposito A, Hernandez ML, Ruiz-Sanz JI, Mendoza R, Matorras R, Sanchez-Tusie AA, Bermudez A, Lopez P, Churchill GC, Trevino CL, Maldonado I, Dabbah J. POSTER VIEWING SESSION - ANDROLOGY. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.75] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
32
|
Gianaroli L, Magli MC, Cavallini G, Crippa A, Capoti A, Resta S, Robles F, Ferraretti AP. Predicting aneuploidy in human oocytes: key factors which affect the meiotic process. Hum Reprod 2010; 25:2374-86. [PMID: 20616356 PMCID: PMC2922997 DOI: 10.1093/humrep/deq123] [Citation(s) in RCA: 60] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND To estimate the incidence of aneuploidy in relation to patients' characteristics, the type of hormonal stimulation and their response to induction of multiple follicular growth, 4163 first polar bodies (PB1s) were analyzed. METHODS Five hundred and forty four infertile couples underwent 706 assisted conception cycles (640 with poor prognosis indications and 66 controls) in which chromosomal analysis of PB1 for the chromosomes 13, 15, 16, 18, 21 and 22 was performed. Results were evaluated in a multivariate analysis. RESULTS The proportion of normal oocytes was directly correlated (P < 0.01) with (i) the number of mature oocytes and (ii) the establishment of a clinical pregnancy; and inversely correlated (P < 0.01) with (i) female age, (ii) causes of female infertility (endometriosis, abortions, ovulatory factor), (iii) poor prognosis indications (female age, number of previous cycles, multiple poor prognosis indications), (iv) number of FSH units per oocyte and (v) number of FSH units per metaphase II oocyte. There was a weak significance of frequency (P < 0.05) between type of abnormality (originated by chromatid predivision, chromosome non-disjunction or combined mechanisms in the same oocyte) and groups of the studied variables, rather than to a specific abnormality or a specific chromosome. CONCLUSIONS The type of infertility had a significant effect on errors derived from the first meiotic division, whose incidence was significantly higher in the presence of endometriosis or of an ovulatory factor, and in women that experienced repeated abortions. Each aneuploidy event was found to be dependent not on a specific variable, but on groups of variables. In addition, the tendency of chromosomal abnormalities to occur simultaneously implies that the deriving aneuploidies can be of any type.
Collapse
Affiliation(s)
- L Gianaroli
- S.I.S.Me.R., Reproductive Medicine Unit, Via Mazzini, 12, 40138 Bologna, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Fujii R, Fujita S, Waseda T, Oka Y, Takagi H, Tomizawa H, Sasagawa T, Makinoda S, Cavagna M, Braga DPAF, Figueira RCS, Aoki T, Maldonado LGL, Iaconelli A, Borges E, Prabhakar S, Dittrich R, Beckmann MW, Hoffmann I, Mueller A, Kjotrod S, Carlsen SM, Rasmussen PE, Holst-Larsen T, Mellembakken J, Thurin-Kjellberg A, Haapaniemi Kouru K, Morin Papunen L, Humaidan P, Sunde A, von During V, Pappalardo S, Valeri C, Crescenzi F, Manna C, Sallam HN, Polec A, Raki M, Tanbo T, Abyholm T, Fedorcsak P, Tabanelli C, Ferraretti AP, Feliciani E, Magli MC, Fasolino C, Gianaroli L, Wang T, Feng C, Song Y, Dong MY, Sheng JZ, Huang HF, Sayyah Melli M, Kazemi-shishvan M, Snajderova M, Zemkova D, Pechova M, Teslik L, Lanska V, Ketel I, Serne E, Stehouwer C, Korsen T, Hompes P, Smulders Y, Voorstemans L, Homburg R, Lambalk C, Bellver J, Martinez-Conejero JA, Pellicer A, Labarta E, Alama P, Melo MAB, Horcajadas JA, Agirregoitia N, Peralta L, Mendoza R, Exposito A, Matorras R, Agirregoitia E, Ajina M, Chaouache N, Gaddas M, Souissi A, Tabka Z, Saad A, Zaouali-Ajina M, Zbidi A, Eguchi N, Jinno M, Watanabe A, Hirohama J, Hatakeyama N, Choi YM, Kim JJ, Kim DH, Yoon SH, Ku SY, Kim SH, Kim JG, Lee KS, Moon SY, Hirohama J, Jinno M, Watanabe A, Eguchi N, Hatakeyama N, Jinno M, Watanabe A, Hirohama J, Eguchi N, Hatakeyama N, Xiong Y, Liang X, Li Y, Yang X, Wei L, Makinoda S, Tomizawa H, Fujita S, Takagi H, Oka Y, Waseda T, Sasagawa T, Fujii R, Utsunomiya T, Chu S, Li P, Akarsu S, Dirican EK, Akin KO, Kormaz C, Goktolga U, Ceyhan ST, Kara C, Nadamoto K, Tarui S, Ida M, Sugihara K, Haruki A, Hukuda A, Morimoto Y, Albu A, Albu D, Sandu L, Kong G, Cheung L, Lok I, Pinto A, Teixeira L, Figueiredo H, Pires I, Silva Carvalho JL, Pereira ML, Faut M, de Zuniga I, Colaci D, Barrios E, Oubina A, Terrado Gil G, Motta A, Colaci D, de Zuniga I, Horton M, Faut M, Sobral F, Gomez Pena M, Motta A, Gleicher N, Barad DH, Li YP, Zhao HC, Spaczynski RZ, Guzik P, Banaszewska B, Krauze T, Wykretowicz A, Wysocki H, Pawelczyk L, Sarikaya E, Gulerman C, Cicek N, Mollamahmutoglu L, Venetis CA, Kolibianakis EM, Toulis K, Goulis D, Loutradi K, Chatzimeletiou K, Papadimas I, Bontis I, Tarlatzis BC, Schultze-Mosgau A, Griesinger G, Schoepper B, Cordes T, Diedrich K, Al-Hasani S, Gomez R, Jovanovic V, Sauer CM, Shawber CJ, Sauer MV, Kitajewski J, Zimmermann RC, Bungum L, Jacobsson AK, Rosen F, Becker C, Andersen CY, Guner N, Giwercman A, Kiapekou E, Zapanti E, Boukelatou D, Mavreli T, Bletsa R, Stefanidis K, Drakakis P, Mastorakos G, Loutradis D, Malhotra N, Sharma V, Kumar S, Roy KK, Sharma JB, Ferraretti A, Gianaroli L, Magli MC, Crippa A, Stanghellini I, Robles F, Serdynska-Szuster M, Spaczynski RZ, Banaszewska B, Pawelczyk L, Kristensen SL, Ernst E, Toft G, Olsen SF, Bonde JP, Vested A, Ramlau-Hansen CH, Wang FF, Qu F, Ding GL, Huang HF, Gallot V, Genro V, Roux I, Scheffer JB, Frydman R, Fanchin R, Kanta Goswami S, Banerjee S, Chakravarty BN, Kabir SN, Seeber BE, Morandell E, Kurzthaler D, Wildt L, Dieplinger H, Tutuncu L, Bodur S, Dundar O, Ron - El R, Seger R, Komarovsky D, Kasterstein E, Komsky A, Maslansky B, Strassburger D, Ben-Ami I, Zhao XM, Ni RM, Lin L, Dong M, Tu CH, He ZH, Yang DZ, Karamalegos C, Polidoropoulos N, Papanikopoulos C, Stefanis P, Argyrou M, Doriza S, Sisi V, Moschopoulou M, Karagianni T, Mentorou C, Economou K, Davies S, Mastrominas M, Gougeon A, De Los Santos MJ, Garcia-Laez V, Martinez-Conejero JA, Horcajadas JA, Esteban F, Labarta E, Crespo J, Pellicer A, Li HWR, Anderson RA, Yeung WSB, Ho PC, Ng EHY, Yang HI, Lee KE, Seo SK, Kim HY, Cho SH, Choi YS, Lee BS, Park KH, Cho DJ, Hart R, Doherty D, Mori T, Hickey M, Sloboda D, Norman R, Huang RC, Beilin L, Freiesleben N, Lossl K, Johannsen TH, Loft A, Bangsboll S, Hougaard D, Friis-Hansen L, Christiansen M, Nyboe Andersen A, Thum MY, Abdalla H, Martinez-Salazar J, De la Fuente G, Kohls G, Pellicer A, Garcia Velasco JA, Yasmin E, Kukreja S, Barth J, Balen AH, Esra T, Var T, Citil A, Dogan M, Cicek N, Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Anifandis G, Messinis IE, Celik O, Hascalik S, Celik N, Sahin I, Aydin S, Hanna CW, Bretherick KL, Liu CC, Stephenson MD, Robinson WP, Louwers YV, Goodarzi MO, Taylor KD, Jones MR, Cui J, Kwon S, Chen YDI, Guo X, Stolk L, Uitterlinden AG, Laven JSE, Azziz R, Navaratnarajah R, Grun B, Sinclair J, Dafou D, Gayther S, Timms JF, Hardiman PJ, Ye Y, Wu R, Ou J, Kim SD, Jee BC, Lee JY, Suh CS, Kim SH, Jung JH, Moon SY, Opmeer BC, Broeze KA, Coppus SF, Collins JA, Den Hartog JE, Land JA, Van der Linden PJ, Marianowski P, Ng E, Van der Steeg JW, Steures P, Strandell A, Mol BW, Tarlatzi TB, Kyrou D, Mertzanidou A, Fatemi HM, Tarlatzis BC, Devroey P, Batenburg TE, Konig TE, Overbeek A, Hompes P, Schats R, Lambalk CB, Carone D, Vizziello G, Vitti A, Chiappetta R, Topcu HO, Yuksel B, Islimye M, Karakaya J, ozat M, Batioglu S, Kuchenbecker WK, Groen H, Bolster JH, van Asselt S, Wolffenbuettel BH, Land JA, Hoek A, Wu Y, Pan H, Chen X, Wang T, Huang H, Zavos A, Dafopoulos K, Georgoulias P, Messini CI, Verikouki C, Messinis IE, Van Os L, Vink-Ranti CQJ, Rijnders PM, Tucker KE, Jansen CAM, Lucco F, Pozzobon C, Lara E, Galliano D, Pellicer A, Ballesteros A, Ghoshdastidar B, Maity SP, Ghoshdastidar B, Ghoshdastidar S, Luna M, Vela G, Sandler B, Barritt J, Flisser ED, Copperman AB, Nogueira D, Prat L, Degoy J, Bonald F, Montagut J, Ghoshdastidar S, Maity S, Ghoshdastidar B, Chen S, Chen X, Luo C, Zhen H, Shi X, Wu F, Ni Y, Merdassi G, Chaker A, Kacem K, Benmeftah M, Fourati S, Wahabi D, Zhioua F, Zhioua A, Saini P, Saini A, Sugiyama R, Nakagawa K, Nishi Y, Jyuen H, Kuribayashi Y, Sugiyama R, Inoue M, Jancar N, Vrtacnik Bokal E, Virant-Klun I, Lee JH, Kim SG, Cha EM, Park IH, Lee KH, Dahdouh EM, Desrosiers P, St-Michel P, Villeneuve M, Fontaine JY, Granger L, Ramon O, Matorras R, Burgos J, Abanto E, Gonzalez M, Mugica J, Corcostegui B, Exposito A, Tal J, Ziskind G, Ohel G, Paltieli Y, Paz G, Lewit N, Sendel H, Khouri S, Calderon I, van Gelder P, Al-Inany HG, Antaki R, Dean N, Lapensee L, Racicot M, Menard S, Kadoch I, Meylaerts LJ, Dreesen L, Vandersteen M, Neumann C, Zollner U, Kato K, Segawa T, Kawachiya S, Okuno T, Kobayashi T, Takehara Y, Kato O, Jayaprakasan K, Nardo L, Hopkisson J, Campbell B, Raine-Fenning N. Posters * Reproductive Endocrinology (i.e. PCOS, Menarche, Menopause etc.). Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.438] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
34
|
Crippa A, Magli MC, Robles F, Capoti A, Ferraretti AP, Gianaroli L, Gallina A, Bonaparte E, Moretti M, Colpi GM, Nerva F, Contalbi G, Vacalluzzo L, Tabano S, Grati FR, Gazzano G, Sirchia SM, Simoni G, Miozzo M, Handyside A, Gabriel A, Thornhill AR, Clemente E, Reitter C, Affara N, Griffin DK, Macek M, Feldmar P, Kluckova H, Hrehorcak M, Diblik J, Paulasova P, Turnovec M, Vilimova S, Macek M, Fontes L, Haddad L, Borges E, Iaconelli A, Braga DPAF, Vianna-Morgante AM, Komsky A, Kasterstein E, Komarovsky D, Bern O, Maslansky B, Kaplan T, Raziel A, Friedler S, Gidoni Y, Ben-Ami I, Ron-El R, Strassburger D, Maggiulli R, Monahan D, Neri QV, Hu JCY, Rosenwaks Z, Palermo GD, Beyazyurek C, Ekmekci GC, Tac HA, Ajredin N, Verlinsky O, Fiorentino F, Kahraman S, Camp M, Hesters L, Le Lorc'h M, Frydman R, Romana S, Frydman N, Perez Sanz J, Matorras R, Arluzea J, Romin Y, Bilbao J, Gonzalez-Santiago N, Manova-Todorova K, Koff A, Rivera-Pomar JM, de la Hoz-Torres C, Xanthopoulou L, Ghevaria H, Mantzouratou A, Serhal P, Doshi A, Delhanty JD, Ye Y, Qian Y, Jin F, Munne S, Gutierrez C, Wagner C, Hill D, Wiemer K, Fischer J, Kaplan B, Danzer H, Surrey M, Opsahl M, Hladikova B, Sobek A, Tkadlec E, Kyselova K, Sobek A, Nichi M, Figueira RCS, Braga DPAF, Setti AS, Iaconelli A, Borges E, Colturato SS, Setti AS, Figueira RCS, Braga DPAF, Iaconelli A, Borges E, Rubio C, Domingo J, Rodrigo L, Mercader A, De los Santos MJ, Pehlivan T, Bosch E, Fernandez M, Simon C, Remohi J, Pellicer A, Perez-Nevot B, Lendinez AM, Palomares AR, Polo M, Rodriguez A, Reche A, Ruiz-Galdon M, Reyes-Engel A, Knauff EAH, Blauw HM, Kok K, Wijmenga C, Fauser BCJM, Franke L, Paffoni A, Paracchini V, Ferrari S, Restelli L, Coviello DA, Scarduelli C, Seia M, Ragni G, Aoyama N, Takehara Y, Kawachiya S, Kuroda T, Kawasaki N, Yamadera R, Suzuki T, Kato K, Kato O, Xu QH, Zhang ZG, Zhou P, Wei ZL, Huang DK, Xing Q, Cao YX, Fauque P, Ripoche MA, Tost J, Journot L, Jouannet P, Vaiman D, Dandolo L, Jammes H, Hellani A, Elsheikh A, Abuamero KK, Elakoum S, Palomares AR, Lendinez AM, Perez-Nevot B, Martinez F, Perez de la Blanca E, Ruiz-Galdon M, Reyes-Engel A, Sobek A, Hladikova B, Tkadlec E, Koutna O, Cepelak T, Kyselova K, Sobek AJR. Posters * Reproductive Genetics (PGD/PGS). Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
35
|
Matsumoto Y, Goto S, Hashimoto H, Kokeguchi S, Shiotani M, Okada H, Cohen - Bacrie P, Hazout A, Belloc S, De Mouzon J, Menezo Y, Dumont M, Junca AM, Cohen-Bacrie M, Alvarez S, Olivennes F, Prisant N, Weltin M, Geissler W, Clussmann C, Strowitzki T, Eggert-Kruse W, Endou Y, Fjii Y, Motoyama H, Quintana FQ, Zaloa Larreategui ZL, Iratxe Penalba IP, Sara Ortega SO, Monica Martin MM, Guillermo Quea GQ, Jose Serna JS, Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ, Zumoffen C, Munuce MJ, Caille A, Ghersevich S, Lendinez AM, Perez-Nevot B, Palomares AR, Serrano Garballo A, Rodriguez A, Reche A, Mayor-Olea A, Ruiz-Galdon M, Reyes-Engel A, Mendiola J, Jorgensen N, Andersson AM, Calafat AM, Redmon JB, Drobnis EZ, Wang C, Sparks A, Thurston SW, Liu F, Swan SH, Tarasconi AC, Tarasconi BV, Tarasconi DV, Silva EMV, Fujii Y, Endou Y, Motoyama H, Crha I, Pribyl J, Skladal P, Zakova J, Ventruba P, Pohanka M, De La Fuente G, Pacheco A, Velasco JAG, Requena A, Pacheco Castro A, San Celestino Carchenilla M, Salvanes R, Arnanz A, Balmori C, Pellicer A, Garcia-Velasco JA, Hashimoto H, Ishikawa T, Goto S, Kokeguchi S, Fujisawa M, Shiotani M, Kranz S, Hersemeyer K, Hentrich A, Tinneberg HR, Konrad L, Simon L, Lutton D, McManus J, Lewis SEM, San Celestino Carchenilla M, Pacheco Castro A, Rubio S, Simon Sanjurjo P, Pellicer A, Garcia-Velasco JA, Lewis S, Lutton D, McManus J, Simon L, Buzzi J, Valcarcel A, Lombardi E, Oses R, Rawe V, Young E, Magendzo A, Lizama S, Duque G, Mackenna A, Lutton D, Simon L, McManus J, Lewis SEM, Monqaut A, Zavaleta C, Lopez G, Lafuente R, Brassesco M, Condorelli R, La Vignera S, La Rosa S, Barone N, Vicari E, Bellanca S, D'Agata R, Calogero AE, Enciso M, Iglesias M, Galan I, Gosalvez A, Gosalvez J, Curaba M, Poels J, Van Langendonckt A, Donnez J, Wyns C, Garcez M, Salvador M, Pasqualotto EB, Braga DPAF, Borges E, Pasqualotto FF, Aoki T, Figueira RCS, Maldonado LGL, Pasqualotto FF, Iaconelli A, Borges E, Frassini R, Mandelli J, Pasqualotto EB, Borges E, Figueira RCS, Braga DPAF, Pasqualotto FF, Borges E, Pasqualotto FF, Figueira RCS, Setti AS, Braga DPAF, Cortezzi SS, Iaconelli A, La Vignera S, Vicari E, Di Mauro M, Burrello N, Condorelli R, D'Agata R, Calogero AE, Kashir J, Jones C, Young C, Ruas M, Grasa P, Rietdorf K, Heytens E, Heindryckx B, Yoon SY, Fissore RA, Deane CM, Nikiforaki D, Tee ST, de Sutter P, Parrington J, Coward K, Visser L, Westerveld GH, van Daalen SKM, van der Veen F, Lombardi MP, Repping S, Cubillos S, Sanchez S, Pedraza J, Charria G, Aparicio H, Gongora A, Caldino F, Cuneo S, Ou JP, Zhao WE, Liu YF, Xu YW, Zhou CQ, Al-Asmar Pinar N, Peinado V, Gruhn J, Susiarjo M, Gil-Salom M, Martinez-Jabaloyas JM, Pellicer A, Remohi J, Rubio C, Hassold T, Peinado V, Al-Asmar N, Gruhn J, Rodrigo L, Gil-Salom M, Martinez-Jabaloyas JM, Pellicer A, Remohi J, Hassold TJ, Rubio C, Bungum M, Forsell N, Giwercman A, Amiri I, Sheikh N, Najafi R, Godarzi M, Farimani M, Makukh H, Tyrkus M, Zastavna D, Nakonechnuy A, Khayat SS, Schileiko LV, Kurilo LF, Garcia-Herrero S, Garrido N, Martinez-Conejero JA, Romany L, Pellicer A, Meseguer M, Dorphin B, Lefevre M, Gout C, Oger P, Yazbeck C, Rougier N, De Stefani S, Scala V, Benedetti S, Tagliamonte MC, Zavagnini E, Palini S, Bulletti C, Canestrari F, Subiran N, Pinto FM, Candenas ML, Agirregoitia E, Irazusta J, Cha EM, Lee JH, Park IH, Lee KH, Kim MH, Jensen MS, Rebordosa C, Thulstrup AM, Toft G, Sorensen HT, Bonde JP, Henriksen TB, Olsen J, Bosco L, Speciale M, Manno M, Amireh N, Roccheri MC, Cittadini E, Wu P, Lee YM, Chen HW, Tzeng CR, Llacer J, Ten J, Lledo B, Rodriguez-Arnedo A, Morales R, Bernabeu R, Garcia-Peiro A, Martinez-Heredia J, Oliver-Bonet M, Ribas J, Abad C, Amengual MJ, Gosalvez J, Navarro J, Benet J, Moutou C, Gardes N, Nicod JC, Becker N, Bailly MP, Galland I, Pirello O, Rongieres C, Wittemer C, Viville S, Elmahaishi W, Smith B, Doshi A, Serhal P, Harper JC, Rennemeier C, Kammerer U, Dietl J, Staib P, Elgmati K, Nomikos M, Theodoridou M, Calver B, Swann K, Lai FA, Georgiou I, Lazaros L, Xita N, Kaponis A, Plachouras N, Hatzi E, Zikopoulos K, Ferfouri F, Clement P, Molina Gomes D, Albert M, Bailly M, Wainer R, Selva J, Vialard F, Takisawa T, Usui K, Kyoya T, Shibuya Y, Hattori H, Sato Y, Ota M, Kyono K, Chiu PC, Lam KK, Lee CL, Chung MK, Huang VW, O WS, Tang F, Ho PC, Yeung WS, Kim CH, Lee JY, Kim SH, Suh CS, Shin YK, Kang YJ, Jung JH, Cha CY, Hwang ES, Mukaida T, Nagaba M, Takahashi K, Elkaffash D, Sedrak M, Huhtaniemi I, Abdel-Al T, Younan D, Cassuto NG, Bouret D, Hammoud I, Yazbeck C, Barak Y, Seshadri S, Bates M, Vince G, Jones DI, Ben Khalifa M, Montjean D, Menezo Y, Cohen-Bacrie P, Belloc S, De Mouzon J, Alvarez S, Aubriot FX, Olivennes F, Cohen M, Prisant N, Boudjema E, Magli MC, Crippa A, Baccetti B, Ferraretti AP, Gianaroli L, Singer T, Neri QV, Hu JC, Maggiulli R, Kollman Z, Rauch E, Schlegel PN, Rosenwaks Z, Palermo GD, Zorn B, Skrbinc B, Matos E, Golob B, Pfeifer M, Osredkar J, Sabanegh E, Sharma RK, Thiyagarajan A, Agarwal A, Robin G, Boitrelle F, Marcelli F, Marchetti C, Mitchell V, Dewailly D, Rigot JM, Rives N, Perdrix A, Travers A, Milazzo JP, Mousset-Simeon N, Mace B, Jakab A, Molnar Z, Benyo M, Levai I, Kassai Z, Golob B, Zorn B, Ihan A, Kopitar A, Kolbezen M, Vaamonde D, Da Silva-Grigoletto ME, Garcia-Manso JM, Vaamonde-Lemos R, Oehninger SC, Walis G, Monahan D, Neri QV, Ermolovich E, Rosenwaks Z, Palermo GD, Fadlon E, Abu Elhija A, Abu Elhija M, Lunenfeld E, Huleihel M, Costantini-Ferrando M, Maggiulli R, Neri QV, Hu JCY, Monahan D, Rosenwaks Z, Palermo GD, Alvarez JG, Gosalvez A, Velilla E, Lopez-Teijon M, Lopez-Fernandez C, Gosalvez J, Tempest HG, Sun F, Oliver-Bonet M, Ko E, Turek P, Martin RH, Zomeno-Abellan MT, Ramirez A, Gutierrez-Adan A, Martinez JC, Landeras J, Ballesta J, Aviles M, Lafuente R, Lopez G, Monqaut A, Brassesco M, Ganaiem M, Binder S, Abu Elhija M, Lunenfeld E, Meinhardt A, Huleihel M, Sousa L, Grangeia A, Carvalho F, Sousa M, Barros A, Sifer C, Sermondade N, Hafhouf E, Poncelet C, Benzacken B, Levy R, Wolf JP, Crisol L, Aspichueta F, Hernandez ML, Exposito A, Matorras R, Ruiz-Larrea MB, Ruiz-Sanz JI, Jallad S, Atig F, Ben Amor H, Saad ALI, Kerkeni A, Ajina M, Othmane ALI, Koscinski I, Ladureau L, Wittemer C, Viville S, Scarselli F, Casciani V, Lobascio M, Minasi MG, Rubino P, Colasante A, Arizzi L, Litwicka K, Iammarrone E, Ferrero S, Mencacci C, Franco G, Zavaglia D, Nagy ZP, Greco E, Ohgi S, Takahashi M, Kishi C, Suga K, Yanaihara A, Chamley LW, Wagner A, Shelling AN. Andrology (Male Fertility, Spermatogenesis). Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
36
|
Bidoli P, Cortinovis DL, Colombo I, Crippa A, Cicchiello F, Villa F, Cazzaniga ME, Altomare G. Impressive efficacy of isotretinoin and clindamycin in treatment of G2/G3 skin rash induced by erlotinib in advanced NSCLC: A pilot study. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e19551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
37
|
Barbiera F, Bosetti A, Ceravolo M, Cortinovis F, Crippa A, Facchin N, Flosi C, Gandolfo C, Juliani E, Leonardi F, Nanni P, Pallini P, Petrelli M, Raganini F, Ravera G, Raiteri U, Riso S, Rovera L, Ruoppolo G, Schindler A, Schindler O, Seneghini A, Sormani M, Sukkar S, Cupillo BT, Van Lint M, Vassallo D. ADI nutritional recommendations for dysphagia. Mediterranean Journal of Nutrition and Metabolism 2009. [DOI: 10.3233/s12349-009-0043-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- F. Barbiera
- U.O. Radiologia “Domenico Noto”, Azienda Ospedali Civili Riuniti, Sciacca (AG), Italy
| | - A. Bosetti
- Scienza dell'Alimentazione, Polo Universitario, Luigi Sacco, e Università degli Studi di Milano, Milan, Italy
| | - M.G. Ceravolo
- Medicina Fisica e Riabilitazione, Università Politecnica delle Marche e Clinica di Neuroriabilitazione, Azienda Ospedali Riuniti di Ancona, Italy
| | - F. Cortinovis
- USSD Dietologia Clinica, Azienda Ospedaliera Ospedali Riuniti, Bergamo, Italy
| | - A. Crippa
- Servizio di Dietologia e Nutrizione Clinica, ASP IMMeS e Pio Albergo Trivulzio, Milan, Italy
| | - N. Facchin
- Servizio di Dietetica e Nutrizione Clinica, Azienda Sanitaria dell'Alto Adige, Comprensorio Sanitario di Bolzano, Italy
| | - C. Flosi
- Villa Scassi, Corso di Laurea in Logopedia, Università degli Studi di Genova, Genoa, Italy
| | - C. Gandolfo
- Centro Ictus, Università degli Studi di Genova, Genoa, Italy
| | - E. Juliani
- U.O. Radiodiagnostica I, Azienda Ospedaliera S. Giovanni Battista, Turin, Italy
| | - F. Leonardi
- U.O. di Scienza dell'Alimentazione e Dietetica, Azienda Ospedaliera “Cannizzaro”, Università degli Studi di Catania, Catania, Italy
| | - P. Nanni
- Servizio di Dietetica e Nutrizione Clinica, ASUR Zona Territoriale 13, Ascoli Piceno, Italy
| | - P. Pallini
- Servizio di Dietetica e Nutrizione Clinica, U.O.C. Gastroenterologia, Azienda ULSS n. 12 Venezia, Mestre (VE), Italy
| | - M. Petrelli
- SOD Dietetica e Nutrizione Clinica, Azienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy
| | - F. Raganini
- UO di Neurologia, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy
| | - G. Ravera
- Dipartimento di Scienze della Salute (DISSAL), Facoltà di Medicina e Chirurgia, Università di Genova, Genoa, Italy
| | - U. Raiteri
- SC Dietetica e Nutrizione Clinica, AO “Maggiore della Carità”, Novara, e Università degli Studi di Pavia, Pavia, Italy
| | - S. Riso
- Responsabile SS Dietetica e Nutrizione Clinica, ASO Ordine Mauriziano, Turin, Italy
| | - L. Rovera
- Responsabile SS Dietetica e Nutrizione Clinica, ASO Ordine Mauriziano, Turin, Italy
| | - G. Ruoppolo
- UOC Foniatria, Policlinico Umberto I, Università degli Studi di Roma “La Sapienza”, Rome, Italy
| | - A. Schindler
- U.O. Otorinolaringoiatria, Azienda Ospedaliera - Polo Universitario “L. Sacco”, Università degli Studi di Milano, Milan, Italy
| | - O. Schindler
- S.C.D.U. Audiologia Foniatria, Università degli Studi di Torino, Turin, Italy
| | - A. Seneghini
- Centro Ictus “Luciano Garello”, UO di Neurologia, Azienda Ospedaliera S. Martino, Genoa, Italy
| | - M.P. Sormani
- Sezione di Biostatistica, Dip. di Scienze della Salute, Università degli Studi di Genova, Genoa, Italy
| | - S.G. Sukkar
- U.O. di Dietetica e Nutrizione Clinica, Azienda Ospedaliera Universitaria S. Martino, Università degli Studi di Genova, Genoa, Italy. e-mail:
| | - B. Travalca Cupillo
- U.O.D. di Foniatria, Azienda Ospedaliera Universitaria S. Martino, Genoa, Italy
| | - M.T. Van Lint
- U.O. Ematologia, Azienda Ospedaliera Universitaria S. Martino, Genoa, Italy
| | - D. Vassallo
- S.S. di Dietetica e Nutrizione Clinica, Stroke-team S.C. Neurologia, ASO Ordine Mauriziano Umberto I, Turin, Italy
| |
Collapse
|
38
|
Magli MC, Gianaroli L, Ferraretti AP, Gordts S, Fredericks V, Crippa A. Paternal contribution to aneuploidy in preimplantation embryos. Reprod Biomed Online 2009; 18:536-42. [DOI: 10.1016/s1472-6483(10)60131-9] [Citation(s) in RCA: 69] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
39
|
Magli MC, Gianaroli L, Crippa A, Grugnetti C, Ruberti A, Ferraretti AP. Causes of aneuploidy – polar body-based PGD. Reprod Biomed Online 2009. [DOI: 10.1016/s1472-6483(10)61200-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
40
|
Gianaroli L, Magli MC, Ferraretti AP, Resta S, Boudjema E, Crippa A. Dilemmas in male factor: role of aneuploidy analysis in male infertility. Reprod Biomed Online 2008. [DOI: 10.1016/s1472-6483(10)61322-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
41
|
Magli MC, Gianaroli L, Lappi M, Crippa A, Robles F, Ferraretti AP. Advanced maternal age. Reprod Biomed Online 2008. [DOI: 10.1016/s1472-6483(10)61315-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
42
|
Cortinovis A, Crippa A, Cavalli R, Corti M, Cattaneo L. Capillary blood viscosity in microcirculation. Clin Hemorheol Microcirc 2006; 35:183-92. [PMID: 16899925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
As known, at the arteriolar level there is the highest resistance to the flow due to the section and to the velocity with an average pressure fall of 50 mmHg (from 85 to 35 mmHg). This resistance is expressed in sec(-1) by the ratio W/2r. This ratio is very high with an average value of 332 sec(-1) and viscosity at this high shear-rate is negligible. At the capillary level the pressure fall is 11.5 mmHg but the vascular resistance W/2r is much lower, on average 32 sec(-1). We can say that if a resistance of 333 sec(-1) corresponds with a pressure fall of 50 mmHg, then a resistance of 32 sec(-1) should correspond with a pressure fall of 4.8 mmHg. The highest pressure fall is due to another kind of resistance which we can define as "Capillary Blood Viscosity" because it depends on the rheological and structural characteristics of the blood. Our instrument reproduces the structure of the capillary district in an experimental model and measures the General Blood Viscosity (GBV) and the Capillary Blood Viscosity (CBV) at the same shear-rate and in particular at the low shear-rate when in non-Newtonian fluids the highest increase in viscosity appears. Consequently, at the capillary, viscosity is dominant with respect to the other geometric and physical resistances. Moreover, the percentage ratio between the GBV and the CBV gives a physical measure of erythrocyte deformability. Knowing viscosity at shear-rate present in the circulatory system, we can obtain the size of RBCs aggregates in the different circulatory districts and their characteristics expressed like "aggregation bond". Changes in CBV are the only possibility in clinical practice to improve the circulatory flow in the capillary district because it is not sure that changes in the arteriolar section can improve the capillary flow or rather open arterio-venous anastomosis. Moreover, in the systemic circulation the aggregate size allows us to point out the phenomenon of cell adhesion because the presence of several receptors involves also the other blood cells. Finally the size and the stability of the RBCs aggregates can modify the endothelial thrombo-resistance.
Collapse
Affiliation(s)
- A Cortinovis
- Dipartimento di Medicina Interna e Terapia Medica, Sez di Clinica Medica 2, Università degli Studi di Pavia, IRCCS Policlinico S. Matteo, Italy
| | | | | | | | | |
Collapse
|
43
|
Abstract
OBJECTIVE To verify if partial or total limitation of degrees of freedom at ankle joints could help patients with balance disorders in standing and walking. DESIGN A cross-over design was chosen. Patients with multiple sclerosis (MS) were tested in three experimental conditions: barefooted, wearing ankle foot orthoses (AFOs), and wearing AFOs that allowed plantar flexion. SETTING Neurorehabilitation unit in a rehabilitation centre. SUBJECTS Fourteen patients suffering from MS with mild strength problems and balance disorders that required them to use walking aids outside. MAIN OUTCOME MEASURES Tests inferring static and dynamic skills were carried out in the three experimental conditions described above. RESULTS Improvements were obtained in static balance tests especially wearing dynamic AFOs; the number of patients who were able to pass tasks on balance in upright position such as 'standing with feet together, head extended' increased from three to nine. Dynamic balance was impaired especially with static AFOs; the time spent walking 10 metres with these orthoses increased by 172% with respect to barefoot; less difference (113%) has been reported wearing dynamic AFOs. CONCLUSION Static and dynamic AFOs improved static balance, while dynamic balance was impaired especially by static AFOs; less negative influence on dynamic balance has been found while wearing dynamic AFOs.
Collapse
Affiliation(s)
- D Cattaneo
- Don Gnocchi Foundation IRCCS, Onlus-Milano, V. Capecelatro 66-20148 Milano, Italy.
| | | | | | | |
Collapse
|
44
|
Gianaroli L, Magli MC, Ferraretti AP, Munné S, Balicchia B, Escudero T, Crippa A. Possible interchromosomal effect in embryos generated by gametes from translocation carriers. Hum Reprod 2002; 17:3201-7. [PMID: 12456624 DOI: 10.1093/humrep/17.12.3201] [Citation(s) in RCA: 81] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND The incidence of abnormal pregnancies in carriers of balanced translocations depends strictly on the chromosomes involved in the translocations. The aim of this study was to verify whether conventional aneuploidy screening could be advantageously combined with preimplantation genetic diagnosis (PGD) for translocations. METHODS Twenty-eight carriers of Robertsonian and reciprocal translocations underwent 43 PGD cycles; specific probes were used to screen the translocation in 172 embryos generated by 35 cycles; most of these embryos were also screened for chromosomes 13, 16, 18, 21, 22 (n = 166), XY (n = 107), 1 (n = 17) and 15 (n = 88). For the remaining eight cycles (carriers of reciprocal translocations) only the chromosomes involved in common aneuploidy screening were investigated on the 40 embryos generated in vitro. RESULTS In Robertsonian translocations, the proportion of embryos with abnormalities due to the translocation was 21%, common aneuploidies contributed 31% of total abnormalities, whereas the remaining 36% of embryos had abnormalities due to both types of chromosome. For reciprocal translocations, the chromosomes involved in the translocation were responsible for 65% of total abnormalities; only 6% of the embryos were abnormal for common aneuploidies and 16% carried abnormalities due to both the chromosomes involved in the translocation and those not related to the translocation. CONCLUSIONS An interchromosomal effect seems to play a role in the case of Robertsonian translocations, where the relevant contribution of aneuploidy exposes the couple to an additional risk of abnormal pregnancy.
Collapse
Affiliation(s)
- L Gianaroli
- SISMER, Reproductive Medicine Unit, Via Mazzini 12, 40138 Bologna, Italy.
| | | | | | | | | | | | | |
Collapse
|
45
|
Russo P, Ottoboni C, Malacarne D, Crippa A, Riou JF, O'Connor PM. Nonpeptidomimetic farnesyltransferase inhibitor RPR-115135 increases cytotoxicity of 5-fluorouracil: role of p53. J Pharmacol Exp Ther 2002; 300:220-6. [PMID: 11752120 DOI: 10.1124/jpet.300.1.220] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
A new nonpeptidic farnesyltransferase inhibitor, RPR-115135, in combination with 5-fluorouracil (5-FU) was studied in an isogenic cell line model system consisting of human colon cancer HCT-116 cells. HCT-116 cells were transfected with an empty control pCMV vector and with a dominant-negative mutated p53 transgene (248R/W). We found that, relative to control transfectants, there was a slight tendency for the p53 inactivated cells to be less sensitive to 5-FU after 6 days of continuous treatment. Simultaneous administration of RPR-115135 and 5-FU, at equitoxic concentrations, resulted in an enhancement of 5-FU cytotoxicity, especially in the CMV-2 clone. Growth inhibition could be accounted for on the basis of a specific cell cycle arrest phenotype (G(2)-M arrest in CMV-2 and S arrest in mutated clones), as assayed by flow cytometry. The combination RPR-115135 + 5-FU increases apoptotic events only in the CMV-2 clone.
Collapse
Affiliation(s)
- Patrizia Russo
- Laboratory of Molecular Pharmacology, Division Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
| | | | | | | | | | | |
Collapse
|
46
|
Crippa A. [Clinical problems in the management of the elderly obese and overweight patient]. MINERVA GASTROENTERO 2001; 47:177-80. [PMID: 16493375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Affiliation(s)
- A Crippa
- Istituto Geriatrico Riabilitativo, Pio Albergo Trivulzio--Milano, Servizio di Dietologia e Nutrizione Clinica
| |
Collapse
|
47
|
Ottoboni C, Crippa A, Falugi C, Russo P. Induction of micronuclei by a new non-peptidic mimetic farnesyltransferase inhibitor RPR-115135: role of gene mutations. Mutagenesis 2001; 16:423-30. [PMID: 11507242 DOI: 10.1093/mutage/16.5.423] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
To investigate the relationship between oncogene activation and induction of micronuclei by a new non-peptidic mimetic farnesyltransferase inhibitor, RPR-115135, two isogenic cell lines, human colon cancer line HCT-116, which harbors a K-ras mutation, and spontaneously immortalized human breast epithelial cell line MCF-10A, were utilized. HCT-116 cells were transfected with an empty control pCMV vector (clone CMV-2) or with a dominant negative mutated p53 transgene (clone Mu-p53-2) to disrupt p53 function. In both clones RPR-115135 induced a significant increase in the frequency of micronucleation at concentrations that did not affect cell membrane integrity. RPR-115135 produced a significant increase in the ratio of CREST+ to CREST- micronuclei. MCF-10A cells were stably transfected with either c-Ha-ras or c-erbB-2 or both H-ras + c-erbB-2. No induction of micronuclei was observed. No induction of micronuclei was reported in human lymphocytes and in primary spinal cells obtained from 7-day chick embryos. In conclusion, RPR-115135 acts as an aneugenic agent in a complex manner, dependent upon the complement of mutations in cell regulatory genes in tumour cells and this activity may be independent of ras genotype.
Collapse
Affiliation(s)
- C Ottoboni
- Molecular Pathology Section, Laboratory of Experimental Oncology, National Institute for Research on Cancer, Genova, Italy
| | | | | | | |
Collapse
|
48
|
Russo P, Ottoboni C, Crippa A, Riou JF, O'Connor PM. RPR-115135, a new non peptidomimetic farnesyltransferase inhibitor, induces G0/G1 arrest only in serum starved cells. Int J Oncol 2001; 18:855-62. [PMID: 11251185 DOI: 10.3892/ijo.18.4.855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
A new non peptidomimetic farnesyltransferase inhibitor, RPR-115135, was studied in an isogenic cell model system consisting of human colon cancer HCT-116 line. HCT-116 cells were transfected with an empty control pCMV vector or with a dominant-negative mutated p53 transgene to disrupt p53 function. Growth inhibitory effects of RPR-115135 were evaluated on cells growing under different conditions (serum starvation, serum starvation and recovery, nocodazole treatment). The cytotoxic activity of RPR-115135 was independent of the cell cycle status of the target cells. Addition of RPR-115135 only to cells exposed to reduced serum conditions (0.1% FCS) resulted in an enhanced ability of HCT-116 cells to arrest in the G0/G1 phase. This arrest response appeared independent of p53/p21cip1/waf-1 function. A reduction of Cyclin A protein amount by RPR-115135 was observed in both clones. These latter results suggest that RPR-115135 might down-regulate the cell cycle factor that would normally impede G0/G1 arrest.
Collapse
Affiliation(s)
- P Russo
- Molecular Pathology Section, Laboratory of Experimental Oncology, National Cancer Research Institute, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.
| | | | | | | | | |
Collapse
|
49
|
Crippa A. [Hygienic and preventive care. 1. Handwashing]. Soins 1999:57-8. [PMID: 10876603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
|
50
|
Achilli E, Cortinovis A, Ardemagni P, Crippa A. [Rheologic modifications induced by heparin therapy. Capillary blood viscosity, erythrocyte deformability, aggregation index]. Minerva Cardioangiol 1999; 47:95-119. [PMID: 10416313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
BACKGROUND The most important problem with which doctors have to deal every day in their practice, is occlusive vascular disease, at the basis of which there is commonly a process of thrombosis. For this reason, it is very important to define early the subjects at thrombosis risk and an appropriate therapeutic strategy. METHODS We considered 13 inpatients at thrombosis risk, c/o sezione di Clinica Medica I, dipartimento di Medicina Interna e Terapia Medica, Università di Pavia, IRCCS Policlinico S. Matteo, and 12 healthy volunteers, between March and June 1998, evaluating age, sex, weight, diseases and ongoing therapy, hemocytological, hemocoagulational and hemorheological tests before and after heparinic therapy. RESULTS General blood viscosity, measured by the rotational and double-filtration method, presented no significant changes; on the contrary, capillary blood viscosity and erythrocyte deformability, measured by our new double-filtration method, showed respectively an increase and a decrease. CONCLUSIONS Calcium heparin is the most frequently used antithrombotic drug in thrombotic diseases and their prevention, but its action on the hemorheological profile is not clear. This study showed that it increases erythrocyte aggregation rate and decreases erythrocyte deformability, having a negative effect on the microcirculation.
Collapse
Affiliation(s)
- E Achilli
- Dipartimento di Medicina Interna, Facoltà di Medicina e Chirurgia, Università degli Studi, Pavia
| | | | | | | |
Collapse
|